Presentations in this session:

MOPEB059 Abstract	Efficacy and safety of fosamprenavir/ritonavir (FPV/r) BID or lopinavir/ritonavir (LPV/r) BID in antiretroviral treatment-naive subjects co-infected with hepatitis B (HBV) or C (HCV) and HIV (The KLEAN Study) Presented by Paul Wannamaker, United States Norris D.1, Patel L.2, Rizzardini G.3, McLeroth P.4, Domingo P.5, Kumar P.6, Clotet B.7, Yau L.2, Wannamaker P.2 1Saint Joseph's Comprehensive Research Institute, Florida, United States, 2GlaxoSmithKline, Research Triangle Park, United States, 3Presidio Ospedaliero di Busto Arsizio, Busto Arsizio, Italy, 4Chase Brexton Health Services, Baltimore, United States, 5Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 6Georgetown University Medical Center, Washington, DC, United States, 7Hospital Universitari Germans Trias i Pujol, Barcelona, Spain
MOPEB075 Abstract	Is HAART neuro-effective in all HIV-1-positive patients? Presented by Gabriele R. Arendt, Germany Arendt G.R.1, Nolting T.1 1University Hospital of Duesseldorf, Neurology, Duesseldorf, Germany
MOPEB023 Abstract	Is risk/benefit ratio of isoniazide prophylaxis among TST positive HIV-individuals the same for those with low and high CD4 count? A real-life scenario Presented by Justyna Dominika Kowalska, Poland (TBC) Kowalska J.D.1, Zalewska-Schönthaler N.2, Schönthaler-Humiecka J.2, Firlag-Burkacka E.1, Horban A.1 1Hospital for Infectious Diseases in Warsaw, Out-patient Clinic, Warsaw, Poland, 2Hospital for Infectious Diseases in Warsaw, Mycobacteriology Laboratory, Warsaw, Poland
MOPEB053 Abstract	Isolated antibodies to hepatitis B core antigen: clinical differences among HIV-positive and HIV-negative patients Presented by Teresa Pérez-Rodríguez, Spain (TBC) Pérez-Rodríguez T.1, Sopeña B.1, Ocampo A.1, del Blanco T.2, González-Villaroel P.1, Argibay A.1, Martínez-Vázquez C.1 1Hospital Universitario Xeral-Cíes of Vigo, Infectious Diseases, Vigo, Spain, 2Hospital Universitario Xeral-Cíes of Vigo, Mycrobiology, Vigo, Spain
MOPEB033 Abstract	Joined services TB clinic and HIV clinic in Somdejprayannasangworn hospital, Chiang Rai, Thailand Presented by Pungpith Wannasorn, Thailand Wannasorn P.1, Jaisuda M.1, Srisai P.1 1Somdejprayannasorn Hospital, Communicable Disease Department, Chiangrai, Thailand
MOPEA026 Abstract	Longitudinal analysis of Nef-specific CTL epitopes in a cohort of long-term non-progressors HIV-1 infected patients Presented by Berta Rodes, Spain (TBC) Lopez M.1, Salgado M.1, Benito J.M.1, Toro C.1, Simón A.1, Vicario J.L.2, Soriano V.1, Rodes B.1 1Hospital Carlos III, Infectious Diseases Department, Madrid, Spain, 2Centro de Transfusiones, Madrid, Spain
MOPEC032 Abstract	Low CD4 lymphocyte cell counts among asymptomatic HIV positive individuals: enrolment challenges for research studies and national antiretroviral treatment programme in Botswana Presented by Tumalano Sekoto, Botswana (TBC) Owor A.M.1, Sekoto T.1, Malamba M.D.1, Baitseng T.1, Sepako E.1, Khumotaka B.1, Moyo S.1, Musonda R.1, Makhema J.M.1, Essex M.2, Partners In Prevention 1Botswana-Harvard School of Public Health AIDS Initiative Partnership, Gaborone, Botswana, 2Harvard School of Public Health, Boston, United States
MOPEA024 Abstract	Low frequency of G-to-A hypermutations in nef of HIV-infected hemophiliacs with progressing and non-progressing HIV disease Presented by Elisa Vicenzi, Italy (TBC) De Rosa A.1, Coradin T.1, Ghezzi S.1, Strebel K.2, Vicenzi E.1 1San Raffaele Scientific Institute, Milan, Italy, 2NIH, Bethesda, United States
MOPEB005 Abstract	Low incidence of abacavir-associated hypersensitivity reactions in Japanese HIV-1-infected patients Presented by Haruhito Honda, Japan (TBC) Honda H.1, Tsukada K.1, Yazaki H.1, Tanuma J.1, Honda M.1, Gatanaga H.1, Teruya K.1, Tachikawa N.1, Kikuchi Y.1, Oka S.1 1International Medical Center of Japan, AIDS Clinical Center, Tokyo, Japan
MOPEB028 Abstract	Meningitis caused by multidrug-resistant strains of Mycobacterium tuberculosis in patients with AIDS Presented by Juan Ambrosioni Czyrko, Argentina (TBC) Ambrosioni Czyrko J.1, Cecchini D.1, Brezzo C.1, Corti M.1, Pérez M.2, Ambroggi M.2 1Infectious Diseases “Francisco Javier Muñiz” Hospital, Infectious Diseases, Buenos Aires, Argentina, 2Infectious Diseases “Francisco Javier Muñiz” Hospital, Mycobacterial Laboratory, Buenos Aires, Argentina
MOPEB110 Abstract	Methamphetamine and club drug use is frequent among recently infected HIV-positive young men who have sex with men in North Carolina, United States Presented by Christopher Hurt, United States (TBC) Hurt C.1, Green K.2, Torrone E.3, Foust E.4, Leone P.1, Hightow-Weidman L.1 1University of North Carolina at Chapel Hill, Department of Medicine, Division of Infectious Diseases, Chapel Hill, North Carolina, United States, 2University of North Carolina at Chapel Hill, Center for AIDS Research, Chapel Hill, North Carolina, United States, 3University of North Carolina at Chapel Hill, School of Public Health, Department of Epidemiology, Chapel Hill, North Carolina, United States, 4North Carolina Department of Health and Human Services, HIV/STD Prevention and Care Branch, Raleigh, North Carolina, United States
MOPEB095 Abstract	Methamphetamine using HIV-1+ adults have lower CD4+ T cell counts than HIV-1+ adults who do not use methamphetamines Presented by Jason Barbour, United States (TBC) Barbour J.1, Philip S.2, Cohen A.3, Lie Y.4, Weidler J.4, Klausner J.3, Kahn J.1 1University of California, San Francisco, HIV/AIDS Division, San Francisco, United States, 2San Francisco Department of Public Health, Medicine, San Francisco, United States, 3San Francisco Department of Public Health, San Francisco, United States, 4Monogram Biosciences, South San Francisco, United States
MOPEA091 Abstract	Migration of plasmacytoid dendritic cells into herpes simplex type 2 lesions: implications for transmission of HIV Presented by Heather Donaghy, Australia (TBC) Donaghy H.1, Bosnjak L.1, Harman A.1, Marsden V.1, Cunningham A.L.2 1Westmead Millennium Institute, Centre for Virus Research, Westmead NSW, Australia, 2Westmead Millennium Institute and University of Sydney, Westmead NSW, Australia
MOPEC016 Abstract	Modelling HIV/AIDS epidemics in Nigeria using UNAIDS/WHO approach to national HIV estimates Presented by Onoja Matthew Akpa, Nigeria (TBC) Akpa O.M.1, Oyejola B.A.2, Ibrahim W.M.3, Akintunde E.A.4 1Redeemer's University, Department of Mathematical Sciences, Redemption Camp, Nigeria, 2University of Ilorin,, Department of Statistics, Ilorin, Nigeria, 3Olabisi Onabanjo University, Department of Mathematical sciences, Ago-Iwoye, Nigeria, 4Institute of Human Virology, Laboratory Service, Maitama, Abuja, Nigeria
MOPEC025 Abstract	Modelling the effect of education and prevention programs on the HIV/AIDS epidemic among homosexual men in New South Wales, Australia Presented by Karina Razali, Australia (TBC) Razali K.1, Hales J.2, Law M.1 1National Centre in HIV Epidemiology and Clinical Research, Sydney, Australia, 2Health Outcomes International, Adelaide, Australia
MOPEA011 Abstract	Molecular characterization of gag, pol and env genes of feline immunodeficiency virus isolates from domestic cats under NRTI treatment or treatment-naïve circulating at Rio de Janeiro, Brazil Presented by Angélica Nascimento Martins, Brazil (TBC) de Oliveira Medeiros S.1, Nascimento Martins A.1, Pascoal Simonetti J.2, Gonçalves Schatzmayr H.2, Tanuri A.1, de Moraes Brindeiro R.1 1Federal University of Rio de Janeiro, Genetics, Rio de Janeiro, Brazil, 2FIOCRUZ, Rio de Janeiro, Brazil
MOPEC006 Abstract	Monitoring HIV incidence among men who have sex with men in Victoria, Australia Presented by Jane Goller, Australia (TBC) Goller J.1, Hellard M.1, Lim M.1, Leslie D.2, Fairley C.3, Higgins N.4, Grulich A.5, Miller E.2, Guy R.6 1Macfarlane Burnet Institute for Medical Research and Public Health, Centre for Epidemiology and Population Health Research, Melbourne, Australia, 2Victorian Infectious Diseases Reference Laboratory, North Melbourne, Australia, 3Melbourne Sexual Health Centre, Carlton, Australia, 4Department of Human Services, Communicable Disease Control Unit, Public Health Branch, Melbourne, Australia, 5National Centre for HIV Epidemiology and Clinical Research, Sydney, Australia, 6Macfarlane Burnet Institute for Medical Research and Public Health, Centre for Epidemiology and Population Health Research, Melbourne, Australia, Department of Epidemiology and Preventative Medicine, Monash University, Melbourne, Australia
MOPEA066 Abstract	Multi-centre evaluation of HLA-B*5701 allele detection by SSP-PCR typing: a quality assurance initiative Presented by David Nolan, Australia (TBC) Hammond E.1, Almeida C.-A.1, Mamotte C.2, Nolan D.1, Phillips E.1, Schollaardt T.3, Gill M.J.3, Angel J.B.4, Neurath D.4, Li J.4, Giulivi T.4, McIntyre C.5, Koultchitski G.6, Wong B.6, Reis M.6, Rachlis A.6, Cole D.E.6, Chew C.B.7, Neifer S.8, Mallal S.1 1Murdoch University, Centre for Clinical Immunology and Biomedical Statistics, Perth, Australia, 2Curtin University, Biomedical Sciences, Perth, Australia, 3University of Calgary, Health Sciences Centre, Calgary, Canada, 4Ottawa Hospital, Transfusion Medicine, Ottawa, Canada, 5Royal Victoria Hospital, Tissue Typing, Montreal, Canada, 6Sunnybrook and Women’s College Health Sciences Centre, Anatomic Pathology, Toronto, Canada, 7Westmead Hopsital, HIV Laboratory, Westmead, Australia, 8Centre for Microbiology and Infectious Epidemiology, Berlin, Germany
MOPEA012 Abstract	Multiple sclerosis and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP): molecular mimicry between myelin basic protein (MBP) and HTLV-1, -2 Gag p15, human herpes virus-6 U24 and multiple sclerosis retrovirus (MSRV) gag capside at the triproline motif Presented by Adrien Caprani, France (TBC) Caprani A.1, Tran M.K.G.2 1Association 'Positifs', Glaire, France, 2CHU-R Gabriel Montpied Clermont-France, Chatenay-Malabry, France
MOPEA003 Abstract	Mutations in capsid major homology region affect assembly and membrane affinity of HIV-1 Gag Presented by Chin-Tien Wang, Taiwan, Province of China (TBC) Wang C.-T.1, Chang Y.-F.1, Huang K.-J.2, Wang S.-M.1 1National Yang-Ming University, Taipei, Taiwan, Province of China, 2Taipei Veterans General Hospital, Department of Medical Research and Education, Taipei, Taiwan, Province of China
MOPEB048 Abstract	Neuropsycological dusturbances (NPS) predict a lower rate of rapid virologic response (RVR) and early virologic response (EVR) in HIV/HCV co-infected patients treated with pegylated interferon alpha 2-a (Peg/IFN) and ribavirin (RBV) Presented by Giuliana Cologni, Italy (TBC) Nasta P.1, Antonelli S.1, Compostella S.1, Cologni G.1, Borghi F.1, Matti A.1, Ricci A.1, Puoti M.1, Gatti F.1, Carosi G.1 1Institute for Infectious and Tropical Diseases, University of Brescia, Brescia, Italy
MOPEB013 Abstract	No observable correlation between central nervous system side effects and EFV plasma concentrations in Japanese HIV-1 infected patients treated with EFV containing HAART Presented by Masaaki Takahashi, Japan (TBC) Takahashi M.1, Ibe S.2, Kudaka Y.1, Okumura N.1, Hirano A.1, Suzuki T.1, Mamiya N.2, Hamaguchi M.2, Kaneda T.2 1National Hospital Organaization Nagoya Medical C., Pharmacy, Clinical Reseach Center, Nagoya, Japan, 2National Hospital Organaization Nagoya Medical C., Clinical Reseach Center, Nagoya, Japan
MOPEA006 Abstract	Nucleotide changes in the HIV RRE cause resistance to anti-Rev compounds Presented by David Rekosh, United States (TBC) Shuck-Lee D.1, Ptak R.2, Hammarskjold M.-L.1, Rekosh D.1 1University of Virginia, Microbiology and Myles H. Thaler Center for AIDS and Human Retrovirus Research, Charlottesville, VA, United States, 2Southern Research Institute, Department of Infectious Disease Research, Frederick, MD, United States
MOPEB093 Abstract	Nutritional status of children attending the AMPATH Clinics in Western Kenya Presented by Samuel Ayaya Olwambula, Kenya (TBC) Ayaya Olwambula S.1, Nyandiko W.1, Mwangi A.2 1Moi University, Child Health and Paediatrics, Eldoret, Kenya, 2Moi University, AMPATH, Eldoret, Kenya
MOPEB043 Abstract	Occult HBV infection in a cohort of HIV positive patients: assessment of liver fibrosis using liver stiffness measurement Presented by Nicoletta Marino, Italy (TBC) Marino N.1, Lo Caputo S.1, Pierotti P.1, Blè C.1, Riccardi M.P.2, Trezzi M.2, Toti M.2, De Gennaro M.3, Scasso A.3, Vivarelli A.4, Dionisio D.4, Mazzotta F.1 1S.M.Annunziata Hospital, Infectious Diseases, Firenze, Italy, 2Misericordia Hospital, Infectious Diseases, Grosseto, Italy, 3Campo di Marte Hospital, Infectious Diseases, Lucca, Italy, 4Del Ceppo Hospital, Infectious Diseases, Pistoia, Italy
MOPEB101 Abstract	Ophthalmic manifestations in HIV infections in India in the era of highly active antiretroviral therapy: a period of transition Presented by Sujit Gharai, India (TBC) Gharai S.1, Garg S.P.1, Venkatesh P.1, Sharma S.K.2, Vohra R.1 1Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, Ophthalmology, New Delhi, India, 2All India Institute of Medical Sciences, New Delhi, Medicine, New Delhi, India
MOPEB096 Abstract	Organisms and antibiotic resistance profiles of nasopharynx or blood isolates from HIV-infected children – predominance of extended spectrum betalactamase (ESBL) producing Enterobactereaceae and other resistant organisms Presented by Mark Cotton, South Africa (TBC) Cotton M.1, Wasserman E.2, Smit J.2, Whitelaw A.3, Zar H.4 1Stellenbosch University, Paediatrics and Child Health, Tygerberg, South Africa, 2Stellenbosch University, Medical Microbiology, Tygerberg, South Africa, 3University of Cape Town, Medical Microbiology, Cape Town, South Africa, 4University of Cape Town, School of Child and Adolescent Health, Cape Town, South Africa
MOPEB035 Abstract	Outcome of tuberculosis in advanced HIV-infected patients with antiretroviral therapy Presented by Punnee Pitisuttithum, Thailand Saito W.1, Pitisuttithum P.1, Tansuphasawadikul S.2, Dhitavat J.1, Phonrat B.1, Chamnachanan S.1, Kim J.3 1Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, 2Bamrasnaradura Institute, Nontaburi, Thailand, 3Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
MOPEA014 Abstract	Partial restoration of IPCs level in HAART treated HIV infected individuals in China Presented by Kunxue Hong, China (TBC) Hong K.1, Feng Y.1, Chen J.1, Ruan Y.1, Xing H.1, Shao Y.1 1National Center for AIDS/STD Control and Prevention, Beijing, China
MOPEB031 Abstract	Patterns of multi-drug resistant TB in persons with HIV disease in Southern India Presented by RAMACHANDRAN VIGNESH, India (TBC) Vignesh R.1, Balakrishnan P.1, Shankar E.1, Murugavel K.G.1, Hanas S.1, Anitha J.C.1, Thyagarajan S.P.1, Suniti S.1, Kumarasamy N.1 1YRG Center for AIDS Research & Education, Chennai, India
MOPEB045 Abstract	Pegylated interferon alfa-2a (PEG-IFN) + ribavirin (RBV) in HIV infected individuals within the Australian Trial of Acute Hepatitis C (ATAHC) achieves end of treatment response (ETR) in over 80% of individuals Presented by Gail Matthews, Australia (TBC) Matthews G.1, Hellard M.2, Sasadeusz J.3, Marks P.1, Yeung B.1, Baker D.4, Bloch M.5, Rawlinson W.6, Lloyd A.7, Kaldor J.1, Dore G.1, ATAHC Study Group 1National Centre In HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia, 2The Macfarlane Institute for Medical Research and Public Health, and The Royal Melbourne Hospital, Melbourne, Australia, 3The Royal Melbourne Hospital, Mebourne, Australia, 4407 Doctors, Sydney, Australia, 5Holdsworth House Primary Care Practice, Sydney, Australia, 6Virology Division, SEALS Microbiology, Prince of Wales Hospital, Sydney, Australia, 7School of Medical Sciences, UNSW, Sydney, Australia
MOPEB018 Abstract	People living with HIV are not accessing TB prevention, diagnosis and treatment: latest data from the tuberculosis global monitoring database Presented by Alasdair Reid, Switzerland Gunneberg C.1, Reid A.2, Williams B.1, Watt C.1, Floyd K.1, Hosseini M.1, Getahun H.1, Scano F.1, Dye C.1, Nunn P.1 1World Health Organisation, Stop TB Department, Geneva, Switzerland, 2The Joint United Nations Programme on HIV/AIDS, Geneva, Switzerland
MOPEB022 Abstract	Performance of a T cell based assay for the diagnosis of tuberculosis in HIV-infected children Presented by Mary-Ann Davies, South Africa (TBC) Davies M.-A.1, Connell T.2, Wood K.3, Beatty D.4, Zar H.4, Nicol M.5, Wilkinson R.6, Wilkinson K.6, Curtis N.7, Johannisen C.3, Pienaar S.3, Eley B.4 1University of Cape Town, Infectious Diseases Epidemiology Unit, School of Public Health and Family Medicine; School of Child and Adolescent Health and Red Cross Children's Hospital, Cape Town, South Africa, 2University of Cape Town, South Africa, School of Child and Adolescent Health and Institute of Infectious Diseases and Molecular Medicine; Infectious Diseases Unit, Department of General Medicine, and Murdoch Children’s Research Institute, Royal Children’s Hospital, Melbourne, Australia, 3University of Cape Town, School of Child and Adolescent Health, Cape Town, South Africa, 4University of Cape Town, Red Cross Children's Hospital and School of Child and Adolescent Health, Cape Town, South Africa, 5University of Cape Town, Institute of Infectious Diseases and Molecular Medicine and School of Child and Adolescent Health, Cape Town, South Africa, 6University of Cape Town, Institute of Infectious Diseases and Molecular
MOPEA064 Abstract	Polymorphism and drug selected mutations in the reverse transcriptase gene of human immunodeficiency virus type 1 from 102 patients living in China Presented by Li Liu, China (TBC) Liu L.1, Lu H.1, Tamalet C.2 1Shanghai Public Health Center, Department of Infectious Disease, Shanghai, China, 2Hôpital de la Timone, Laboratoire de Virologie, Marseille, France
MOPEA040 Abstract	Potent restriction of HIV-1 infection in vitro in CD34 cell derived macrophages and in vivo in SCID-hu derived T cells by lentiviral vector expressed chimeric human and rhesus macaque TRIM5α Presented by Joseph Anderson, United States (TBC) Anderson J.1, Akkina R.1 1Colorado State University, Microbiology/Immunology/Pathology, Fort Collins, United States
MOPEB050 Abstract	Predictors of insulin resistance (IR) in HIV/HCV co-infected patients treated with pegylated interferon alpha 2-a (Peg/IFN) and ribavirin (RBV) Presented by Alessandro Matti, Italy (TBC) Matti A.1, Nasta P.1, Borghi F.1, Cologni G.1, Ricci A.1, Gatti F.1, Puoti M.1, Carosi G.1 1University of Brescia, Institute of Infectious and Tropical diseases, Brescia, Italy
MOPEB066 Abstract	Prevalence and factors associated with renal failure in HIV infected patients, ANRS C03 Aquitaine Cohort, France Presented by Philippe Jean Marie MORLAT, France (TBC) Morlat P.J.M.1, Deti E.2, Lawson-Ayayi S.2, Bonnet F.1, Dupon M.3, Geffard S.2, Pellegrin J.L.4, Decoin M.5, Mercie P.1, Tchamgoue S.6, Dabis F.2, Groupe d'Epidemiologie du SIDA en Aquitaine 1Hopital Saint Andre, Internal Medicine Department, Bordeaux, France, 2INSERM U 593, Universite Bordeaux 2, Bordeaux, France, 3Hopital Pellegrin, Infectious Diseases Department, Bordeaux, France, 4Hopital Haut-Leveque, Internal Medicine Department, Bordeaux, France, 5COREVIH, University Hospital, Bordeaux, France, 6Hopital Robert Boulin, Internal Medecine Department, Libourne, France
MOPEC026 Abstract	Prevalence of HIV infection among injecting drug users in Taiwan in the beginning of harm reduction program Presented by Yu-Ching Lan, Taiwan, Province of China (TBC) Lan Y.-C.1, Chen Y.-M.2 1China Medical University, Department of Health Risk Management, Taichung, Taiwan, Province of China, 2National Yang-Ming University, AIDS Prevention and Research Center, Taipei, Taiwan, Province of China
MOPEC014 Abstract	Prevalence of HIV-2 infection in South Tamil Nadu, South India Presented by Rajanayagam Anburajan, India (TBC) Anburajan R.1 1Peace Trust, Tirunelveli, India
MOPEB068 Abstract	Prevalence of renal failure in a HAART cohort in Cambodia and its effect on the occurrence of NRTI-related side effects Presented by Sovannara Thay, Cambodia (TBC) Thay S.1, An S.1, Koole O.2, De Munter P.3, Lynen L.2, Verpooten G.4 1Sihanouk Hospital Center of Hope, Infectious Diseases, Phnom Penh, Cambodia, 2Institute of Tropical Medicine, Clinical Sciences, Antwerp, Belgium, 3Universitaire Ziekenhuizen, General Internal Medicine, Leuven, Belgium, 4University of Antwerp, Antwerp, Belgium
MOPEC011 Abstract	Prevention of HIV transmission in Nigeria: role of a dentist Presented by CLEMENT AZODO, Nigeria (TBC) Azodo C.1, Ehizele A.1, Umoh A.2, Ogbebor G.3 1University of Benin Teaching Hospital, Periodontics, Benin-City, Nigeria, 2School Of Dentistry, University Of Benin, Periodontics, Benin-City, Nigeria, 3Dental Center General Hospital Minna, General Dental Practice, Minna, Nigeria
MOPEA084 Abstract	Primary HIV-1 infection facilitating acute hepatitis B infection despite adequate antibody to hepatitis B surface antigen Presented by Carol R Emerson, Australia (TBC) Emerson C.R.1, Kelly M.D.2, Post J.J.1 1Prince of Wales Hospital, Infectious Diseases, Sydney, Australia, 2AIDS Medical Unit, Brisbane, Australia
MOPEB098 Abstract	Prognostic factors associated with the restoration of Toxoplasma gondii (Tg) specific T cell immune responses in patients with AIDS starting antiretroviral therapy (ART): a prospective study Presented by Jean-Michel Molina, France (TBC) Furco A.1, Carmagnat M.2, Garin Y.J.-F.3, Pavie J.1, De Castro N.1, Carel O.1, Charron D.2, Derouin F.3, Rabian C.4, Chevret S.5, Molina J.-M.6 1Saint-Louis Hospital, Infectious Diseases, Paris, France, 2Saint-Louis Hospital, Immunology, Paris, France, 3Saint-Louis Hospital, Parasitology, Paris, France, 4Saint-Louis Hospital, Immunology, Paris, Finland, 5Saint-Louis Hospital, Biostatistics, Paris, France, 6University of Paris 7, Denis Diderot, Paris, France
MOPEC036 Abstract	Program B.R.I.E.F: high volume, rapid HIV testing in an urban ED Presented by Yvette Calderon, United States (TBC) Calderon Y.1, Leider J.2, Hailpern S.M.3, Haughey M.4, Lombardi P.5, Huang D.6, Jordan N.6, Bijur P.E.6, Bauman L.J.7 1Albert Einstein College of Medicine, Emergency Medicine, New York, United States, 2Albert Einstein College of Medicine, Internal Medicine, Bronx, United States, 3Albert Einstein College of Medicine, Department of Epidemiology & Population Health, Bronx, United States, 4Department of Epidemiology & Population Health, Emergency Medicine, Bronx, United States, 5Albert Einstein College of Medicine, Bronx, United States, 6Albert Einstein College of Medicine, Emergency Medicine, Bronx, United States, 7Albert Einstein College of Medicine, Pediatrics, Bronx, United States
MOPEA022 Abstract	Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation Presented by Andrew Lim, Australia (TBC) Lim A.1, Price P.1, French M.2 1University of Western Australia, School of Surgery and Pathology, Perth, Australia, 2Royal Perth Hospital, Department of Clinical Immunology and Immunogenetics, Perth, Australia
MOPEB032 Abstract	Provider-initiated HIV counseling and testing for TB patients increases access to HIV care and treatment in Ethiopia: the ICAP experience Presented by Zenebe Melaku, Ethiopia (TBC) Melaku Z.1, Shewangizaw E.1, Shimeles E.1, Zewde A.1, Tizazu G.1, Alemu A.1, Gashu N.1, Rabkin M.2, Tsiouris S.2 1Columbia University, ICAP Ethiopia, Addis Ababa, Ethiopia, 2Columbia University, ICAP-NY, New York, United States
MOPEB049 Abstract	Rate of cirrhosis progression reduced in HIV/HCV co-infected non-responders to anti-HCV therapy Presented by Caterina Uberti-Foppa, Italy De Bona A.1, Galli L.1, Gallotta G.1, Alagna L.1, Lazzarin A.1, Uberti-Foppa C.1 1San Raffaele Hospital, Scientific Institute, Vita-Salute University, Infectious diseases, Milan, Italy
MOPEB015 Abstract	Reasons for switching highly active antiretroviral therapy (HAART) regimens among HIV/AIDS patients in low-resource settings: the case of Mbagathi District Hospital, Kenya Presented by Lilian Kocholla, Kenya Kocholla L.1, Wangai M.2, Kusu N.2, Maundu J.2, Thuo M.2 1Mbagathi District Hospital, Nairobi, Kenya, 2Management Sciences for Health, Rational Pharmaceutical Management Plus Program, Nairobi, Kenya
MOPEB091 Abstract	Reduced absorptive capacity is linked to diminished immune competence in HIV Presented by Brett Ritchie, Australia (TBC) Butler R.1, Zacharakis B.1, Ritchie B.2, Daly L.2, Hawkes J.1, Shaw D.2, Waddell R.2, Davidson G.1 1Women's and Children's Hospital, Gastroenterology Unit, Adelaide, Australia, 2Royal Adelaide Hospital, Infectious Diseases Unit, Adelaide, Australia
MOPEB020 Abstract	Reinforcement of TB screening identifies a high burden of pulmonary tuberculosis among HIV/AIDS patients in the Mulago Immune Suppression Clinic, Uganda Presented by Damalie Nakanjako, Uganda (TBC) Nakanjako D.1, Mwesigire D.1, Wanyenze R.1, Sempira J.1, Ouma J.1, Senkusu J.1, Kamya M.1 1Mulago-Mbarara Teaching Hospitals’ Joint AIDS Program (MJAP), Kampala, Uganda
MOPEB064 Abstract	Renal function changes at two years in HIV-infected patients treated with tenofovir-DF Presented by Homayoon Khanlou, United States (TBC) Javanbakht M.1, Khanlou H.1, Chien C.1, Denouden P.1, Voskanian A.1, Kaur P.1, Farthing C.1 1AIDS Healthcare Foundation, Medicine, Sherman Oaks, United States
MOPEA033 Abstract	Repeated measures analysis of plasma HIV-1 RNA levels in HIV-infected patients remaining on a stable partially suppressive regimen Presented by Hiroyu Hatano, United States (TBC) Hatano H.1, Hunt P.1, Weidler J.2, Coakley E.2, Hoh R.1, Liegler T.3, McCulloch C.1, Martin J.1, Deeks S.G.1 1University of California San Francisco, San Francisco, CA, United States, 2Monogram Biosciences, Inc., South San Francisco, CA, United States, 3University of California San Francisco and Gladstone Institute of Virology and Immunology, San Francisco, CA, United States
MOPEA004 Abstract	Resistance to HIV infection of primary macrophages following siRNA-mediated downregulation of cellular metalloprotease ADAM10 Presented by Brian Friedrich, United States (TBC) Friedrich B.1, Murray J.2, Rubin D.3, Hodge T.2, O'Brien W.4 1University of Texas Medical Branch, Experimental Pathology, Galveston, United States, 2University of Georgia, College of Veterinary Medicine, Athens, United States, 3VA TVHS and Vanderbilt University, Nashville, United States, 4University of Texas Medical Branch, Internal Medicine, Galveston, United States
MOPEC022 Abstract	Risk behaviour among Russian women before and after HIV diagnosis Presented by Irina Eramova, Denmark (TBC) Eramova I.1, Smolskaya T.2, Konovalova N.2, Yakovleva A.3, Gurvich J.3, Matic S.1 1Sexually Transmitted Infections/HIV/AIDS Programme, WHO Regional Office for Europe, Copenhagen, Denmark, 2North-West Regional Centre for AIDS Prevention and Control, St.Petersburg, Russian Federation, 3Public organization for social projects 'Stellit', St.Petersburg, Russian Federation
MOPEB067 Abstract	Risk factors associated with mild renal insufficiency (RI) in HIV-infected patients Presented by Anuradha Ganesan Ganesan, United States (TBC) Ganesan A.G.1, Crum-Cianflone N.2, Riddle M.3, Medina S.2, Barahona I.1, Tasker S.1 1National Naval Medical Center/IDCRP-TACC, Bethesda, United States, 2Naval Medical Center San Diego/IDCRP-TACC, San Diego, United States, 3Naval Medical Research Center, Silver Spring, United States
MOPEB037 Abstract	Risk factors for hepatitis C in HIV positive MSM. A preliminary evaluation of a case control study Presented by Axel J. Schmidt, Germany (TBC) Schmidt A.J.1, Vogel M.2, Rockstroh J.K.2, Radun D.3, Study Group on Sexual Risk Factors for Hepatitis C 1WZB (Social Science Research Center Berlin), Public Health Unit, Berlin, Germany, 2University of Bonn, Medical Department I, Bonn, Germany, 3Robert Koch Institute, Department for Infectious Disease Epidemiology, Berlin, Germany
MOPEB009 Abstract	Risk factors for nevirapine-associated rash among HIV-infected patients with low CD4 cell counts in resource-limited setting Presented by Sasisopin Kiertiburanakul, Thailand (TBC) Kiertiburanakul S.1, Sungkanuparph S.1, Charoenyingwattana A.2, Mahasirimongkol S.3, Sura T.1, Chantratita W.4 1Faculty of Medicine Ramathibodi Hospital, Mahidol University, Department of Medicine, Bangkok, Thailand, 2Ramathibodi Hospital, Mahidol University, Pharmacy Department, Bangkok, Thailand, 3Foreign Affairs Section, Ministry of Public Health, Department of Medical Sciences, Nonthaburi, Thailand, 4Faculty of Medicine Ramathibodi Hospital, Mahidol University, Department of Pathology, Bangkok, Thailand
MOPEB071 Abstract	Risk factors for proteinuria in HIV-infected and -uninfected Hispanic drug abusers Presented by Alice M. Tang, United States Rhee M.1, Schmid C.2, Stevens L.3, Tang A.M.1, Forrester J.4 1Tufts-New England Medical Center, Division of Geographic Medicine and Infectious Diseases, Boston, United States, 2Tufts-New England Medical Center, Biostatistics Research Center, Boston, United States, 3Tufts-New England Medical Center, Division of Nephrology, Boston, United States, 4Tufts Univ School of Medicine, Dept of Public Health and Family Medicine, Boston, United States
MOPEA056 Abstract	Role of the in vivo mutation N348I in the connection domain of the HIV-1 reverse transcriptase in drug resistance Presented by Gilda Tachedjian, Australia (TBC) Yap S.-H.1, Sheen C.-W.2, Kuiper M.3, Dias Lima V.4, Sluis-Cremer N.2, Harrigan R.4, Tachedjian G.1 1Burnet Institute, Molecular Interactions Group, Melbourne, Australia, 2University of Pittsburgh School of Medicine, Division of Infectious Diseases, Pittsburgh, United States, 3Victorian Partnership for Advanced Computing, Melbourne, Australia, 4British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada
MOPEB054 Abstract	Search of occult hepatitis B in a cohort of HIV infected patients with recovered hepatitis B infection Presented by Giovanni Cenderello, Italy (TBC) Cenderello G.1, Toscanini F.2, Tita Farinella S.1, Riccio A.1, Balestra A.1, De Leo P.2, Anselmo M.2, Ferrea G.1 1ASL1 Imperiese, Infectious diseases, Sanremo, Italy, 2ASL2 Savonese, Infectious diseases, Savona, Italy
MOPEA058 Abstract	Sensitive detection of HIV-1 K103N mutation in treatment naïve patients by Rolling Circle Amplification Presented by Bin Wang, Australia (TBC) Wang B.1, Chew J.2, Cunningham A.1, Dwyer D.2, He Z.3, Saksena N.1 1Westmead Millennium Institute, Centre for Virus Research, Sydney, Australia, 2Westmead Hospital, ICPMR, Sydney, Australia, 3Yong An Hospital, Centre of Clinical Laboratory, Beijing, China
MOPEB088 Abstract	Serum and cellular markers of B cell activation are increased several years preceding the diagnosis of AIDS-associated non-Hodgkin´s B cell lymphoma Presented by Elizabeth Crabb Breen, United States (TBC) Breen E.C.1, Magpantay L.1, Epeldegui M.1, Hung Y.P.1, Detels R.2, Kaslow R.3, Rabkin C.4, Ambinder R.5, Jacobson L.P.6, Martinez-Maza O.1 1University of California, David Geffen School of Medicine, Los Angeles, United States, 2University of California, School of Public Health, Los Angeles, United States, 3University of Alabama at Birmingham, School of Medicine, Birmingham, United States, 4National Cancer Institute, Cancer Epidemiology and Genetics, Bethesda, United States, 5Johns Hopkins University, School of Medicine, Baltimore, United States, 6Johns Hopkins University, Bloomberg School of Public Health, Baltimore, United States
MOPEC023 Abstract	Sexual behavior of acutely HIV infected individuals in six US cities, pre and post diagnosis: the potential of acute testing as an HIV intervention Presented by Robert H. Remien, United States (TBC) Remien R.H.1, Steward W.T.2, Higgins J.A.1, Correale J.1, Brooks R.A.3, Dubrow R.4, Pinkerton S.D.5, Sikkema K.6, Morin S.F.2, The Acute HIV Infection Study Team 1New York State Psychiatric Institute & Columbia University, HIV Center for Clinical & Behavioral Studies, New York, NY, United States, 2University of California, San Francisco, Center for AIDS Prevention Studies`, San Francisco, CA, United States, 3University of California, Los Angeles, Center for HIV Identification, Prevention, and Treatment, Los Angeles, CA, United States, 4Yale School of Public Health, Division of Chronic Disease Epidemiology, New Haven, CT, United States, 5Medical College of Wisconsin, Center for AIDS Intervention Research, Miwaukee, WI, United States, 6Duke University, School of Nursing, Durham, NC, United States
MOPEC012 Abstract	Stabilizing trend of HIV infection in Tamilnadu, South India Presented by Jagadeesan Murugesan, India (TBC) Murugesan J.1, Pandurangan S.1, Rajendiran P.1, Sahu S.1 1Tamil Nadu State AIDS Control Society, Health & Family Welfare Department, Chennai, India
MOPEB030 Abstract	Starting Cotrimoxazole prophylactic regimens and ART for HIV-positive TB patients in the African region: latest data from the tuberculosis global monitoring database Presented by Alasdair Reid, Switzerland Scano F.1, Gunneberg C.1, Reid A.2, Williams B.1, Watt C.1, Floyd, K.1, Hosseini M.1, Getahun H.1, Dye C.1, Nunn P.1 1World Health Organisation, Stop TB Department, Geneva, Switzerland, 2Joint United Nations Programme on HIV/AIDS, Geneva, Switzerland
MOPEB085 Abstract	Survival and evolution of the rate of incidence in neoplasms before and after the HAART era Presented by Miguel Cervero, Spain (TBC) Cervero M.1, Torres R.1, Castaño A.2, Rodriquez-Rosado R.1, Jusdado J.J.1, Del Álamo M.3, García-Benaya E.4 1H. Severo Ochoa, Internal Medicine, Madrid, Spain, 2H. Severo Ochoa, Pathology Service, Madrid, Spain, 3H. Severo Ochoa, Microbiology Service, Madrid, Spain, 4H. Severo Ochoa, Pharmacy Service, Madrid, Spain
MOPEA053 Abstract	Synergistic antiretroviral activity of pyrophosphate analogue ANX-201 paired with nucleoside reverse transcriptase inhibitors in vitro Presented by Shani Waninger, United States (TBC) Waninger S.1, Ramos S.1, Robbins J.1 1ADVENTRX Pharmacueticals, Inc, San Diego, United States
MOPEA038 Abstract	The antiviral restriction of a chimeric APOBEC3A protein Presented by Renato Aguiar, United States (TBC) Aguiar R.1, Lovsin N.2, Peterlin B.1 1University of California San Francisco, Department of Medicine, Microbiology and Immunology, San Francisco, United States, 2University of Ljubljana, Slovenia, Faculty of Chemistry and Chemical Technology, Ljubljana, Slovenia
MOPEA031 Abstract	The co-infection of T cells with the HIV-1 laboratory strain RF, harbouring a 100 amino acid truncation of the gp41 cytoplasmic tail and wildtype RF Presented by Judith Edmonds, Australia (TBC) Edmonds J.1, Piler S.1 1Westmead Millennium Institute, Centre for Virus Rsearch, Sydney, Australia
MOPEB026 Abstract	The coughing patient: TB or not TB, that is the question Presented by Natalia Laufer, Argentina (TBC) Laufer N.1, Cabrini M.1, Abusamra L.2, Figueroa M.I.1, Sued O.2, Hansen R.1, Sisto A.1, Pérez H.1, Salomón H.3, Cahn P.1 1Hospital Juan A Fernandez, Infectious Diseases Unit, Buenos Aires, Argentina, 2Huesped Foundation, Buenos Aires, Argentina, 3Argentinean National Reference Center for AIDS, Microbiology Department, University of Buenos Aires, Buenos Aires, Argentina
MOPEB073 Abstract	The CRIPTOGEN study: initial assessment and longitudinal follow-up of HIV cerebrospinal concentrations in patients with cryptococcal meningitis Presented by Jorge Benetucci, Argentina Cecchini D.1, Cañizal A.M.2, Rojas H.1, Cangelosi D.1, Metta H.1, Trione N.1, Prieto R.3, San Juan J.3, Negroni R.4, Bouzas M.B.2, Benetucci J.1 1Infectious Diseases Department, Infectious Diseases Hospital “Francisco J. Muñiz”, Buenos Aires, Argentina, 2Virology Unit, Infectious Diseases Hospital “Francisco J. Muñiz”, Buenos Aires, Argentina, 3Intensive Care Department, Infectious Diseases Hospital “Francisco J. Muñiz”, Buenos Aires, Argentina, 4Mycology Unit, Infectious Diseases Hospital “Francisco J. Muñiz”, Buenos Aires, Argentina
MOPEA060 Abstract	The E399G mutation in the connection domain of the HIV-1 reverse transcriptase potentiates resistance to efavirenz Presented by Gilda Tachedjian, Australia (TBC) Figueiredo A.1, Tyssen D.1, Kuiper M.2, Sonza S.1, Mak J.3, Harrigan R.4, Tachedjian G.1 1Burnet Institute, Molecular Interactions Group, Melbourne, Australia, 2Victorian Partnership for Advanced Computing, Melbourne, Australia, 3Burnet Institute, HIV Assembly Group, Melbourne, Australia, 4BC Centre for Excellence in HIV/AIDS, Vancouver, Canada
MOPEB025 Abstract	The effectiveness of HAART and isoniazid preventive treatment (IPT) in preventing TB in HIV-infected adults - a prospective cohort from two South African sites Presented by Neil Alexander Martinson, South Africa Golub J.1, Pronyk P.2, McIntyre J.A.3, Gray G.E.3, Tshabangu N.3, Struthers H.3, Moshabela M.2, Chaisson R.E.1, Martinson N.A.4 1Johns Hopkins University, Center for TB Research, Baltimore, MD, United States, 2School of Public Health, University of the Witwatersrand, RADAR, Buschbuckridge, Mpumalanga, South Africa, 3Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa, 4Johns Hopkins University, Center for TB Research and PHRU, Johannesburg, South Africa
MOPEA093 Abstract	The effects of mycobacterium tuberculosis on gene expression dominate those of HIV-1 in co-infected macrophages Presented by Susan Maddocks, Australia (TBC) Maddocks S.1, Scandurra G.2, Nourse C.2, Bye C.1, Williams R.3, Slobedman B.4, Britton W.2, Cunningham A.1 1Westmead Millennium Institute, Centre for Virus Research, Sydney, Australia, 2Centenary Institute of Cancer Medicine and Cell Biology, Mycobacterial Research Group, Sydney, Australia, 3University of NSW, School of Biotechnology and Biomolecular Sciences, Sydney, Australia, 4Westmead Millennium Institute, Cytomegalovirus Research Group, Sydney, Australia
MOPEB055 Abstract	The efficacy of high-dose hepatitis B vaccination in HIV-infected individuals Presented by Joseph McGowan, United States (TBC) Bortan A.1, Shah S.1, Epstein M.1, McGowan J.1 1North Shore University Hospital, Infectious Diseases, Manhasset, United States
MOPEC003 Abstract	The evaluation of exposure to HIV in the context of a HIV serodiscordant relationship Presented by Julie Fox, United Kingdom (TBC) Fox J.1, McClure M.1, Weber J.1, Fidler S.1 1Imperial College, Infectious Diseases, London, United Kingdom
MOPEA048 Abstract	The evaluation of position specific scoring matrix (PSSM) for genotypic prediction of co-receptor switching in HIV-1 isolates circulating in Iran Presented by Elham Shirvani, Iran, Islamic Republic of (TBC) Shirvani E.1, Sarrami-Forooshani R.1, Nategh R.2, Haji-Abdolbaghi M.3, Mohraz M.3, Gomari H.1, Doosti A.1, Barkhordari F.1, Adeli A.1, Mahboudi F.1 1Pasteur Institute of Iran, Biotechnology research Center, Tehran, Iran, Islamic Republic of, 2I.A.U. Islamic Azad University. Science and Research Branch, Basic science, Tehran, Iran, Islamic Republic of, 3Imam Khomeini Hospital, Infectious Disease Division, Tehran, Iran, Islamic Republic of
MOPEA068 Abstract	The genetic variability of CYP2B6 polymorphisms in four Southern Chinese populations Presented by Ming-Liang He, China (TBC) He M.-L.1, Dong Q.1, Tan Y.1, Kung H.-f.1, Lee S.S.1 1The Chinese University of Hong Kong, The Stanley Ho Center for Emerging Infectious Diseases, Hong Kong, China
MOPEA051 Abstract	The impact of imperfect vaccines on the evolution of HIV virulence Presented by Eduardo Massad, Brazil (TBC) Massad E.1, Coutinho F.A.B.1, Lopez L.F.1, Burattini M.N.1 1School of Medicine, The University of São Paulo, Medical Informatics - Department of Pathology, São Paulo, Brazil
MOPEB092 Abstract	The impact of malnutrition on survival and immunological response in HIV infected patients starting antiretroviral therapy (ART) in Uganda Presented by Bonnie Wandera, Uganda (TBC) Wandera B.1, Castelnuovo B.1, Kiragga A.1, Kambugu A.1, Mayanja Kizza H.2, McAdam K.1, Kamya M.R.2 1Infectious Diseases Institute, Makerere University, Adult Infectious Diseases Clinic, Kampala, Uganda, 2Makerere University Medical School, Department of Medicine, Kampala, Uganda
MOPEA089 Abstract	The pattern of HIV infection in human lymphoid tissue is determined by interactions with non-HIV viruses Presented by Leonid Margolis, United States (TBC) Margolis L.1 1National Institute of Health, Child Health and Human Development, Bethesda, United States
MOPEB058 Abstract	The risk of liver toxicity in HIV patients treated with tipranavir is related to hepatitis C, liver fibrosis stage and plasma drug levels Presented by Francisco Blanco, Spain Garcia-Gasco P.1, Morello J.2, Barreiro P.1, Maida I.1, Blanco F.1, Gonzalez-Pardo G.2, García-Merchan J.A.1, Rodriguez-Novoa S.2, Jimenez I.2, Soriano V.1 1Hospital Carlos III, Servicio de Enfermedades Infecciosas, Madrid, Spain, 2Hospital Carlos III, Pharmacokinetic Unit, Madrid, Spain
MOPEB081 Abstract	The spectrum of human immunodeficiency virus-associated cancers in South Africa: results from a case control study, 1995 - 2004 Presented by Freddy Sitas, Australia (TBC) Stein L.1, Urban M.1, O'Connell D.2, Yu X.Q.2, Beral V.3, Newton R.3, Ruff P.4, Donde B.5, Hale M.6, Patel M.7, Sitas F.8 1National Health Laboratory Service, Cancer Epidemiology Research Group, Johannesburg, South Africa, 2The Cancer Council NSW, Cancer Epidemiology Research Unit, Sydney, Australia, 3Epidemiology Unit, Cancer Research UK, Oxford, United Kingdom, 4University of the Witwatersrand, Faculty of Health Sciences, Johannesburg, South Africa, 5University of the Witwatersrand, Radiation Therapy, Johannesburg, South Africa, 6National Health Laboratory Service, Pathology, Johannesburg, South Africa, 7University of the Witwatersrand, Haematology, Johannesburg, South Africa, 8The Cancer Council NSW, Research Division, Sydney, Australia
MOPEB012 Abstract	Tolerability of emtricitabine (FTC) in HIV infected subjects who switch from lamivudine (3TC) to FTC Presented by Sara Villar del Saz, Spain (TBC) Villar del Saz S.1, Milinkovic A.2, Domingo P.3, Podzamczer D.4, Gonzalez A.5, Ocaña I.1, de Lazzari E.2, Knobel H.5, Gatell J.M.2, Clotet B.6, Ribera E.1 1Hospital Universitario Valle Hebron, Servicio de Enfermedades Infecciosas, Barcelona, Spain, 2Hospital Clínic-IDIBAPS, Servicio de Enfermedades Infecciosas, Barcelona, Spain, 3Hospital de Sant Pau, Servicio de Enfermedades Infecciosas, Barcelona, Spain, 4Hospital Prínceps d'Espanya, Servicio de Enfermedades Infecciosas, Hospitalet de Llobregat. Barcelona, Spain, 5Hospital del Mar, Servicio de Enfermedades Infecciosas, Barcelona, Spain, 6Hospital Germans Trías i Pujol, Servicio de Enfermedades Infecciosas, Badalona (Barcelona), Spain
MOPEA067 Abstract	Towards safer antiretroviral therapy: ligation-mediated PCR as a tool to unravel and predict toxicities Presented by David Hooker, Australia (TBC) Hooker D.1, Wesselingh S.1, Cherry C.1 1Burnet Institute, Melbourne, Australia
MOPEB029 Abstract	Treatment outcome and survival for HIV/AIDS patients co-infected with mycobacterium tuberculosis in Argentina Presented by Jorge Contarelli, Argentina (TBC) Contarelli J.1, Cucchetti A.1, Massera L.1, Michaan M.1, Sarobbe R.1, Sanchez Viamonte J.1, Dellavedova A.1, Stagnaro J.P.1, Lindow R.1 1Hospital San Juan de Dios, Infectious Diseases, La Plata, Argentina
MOPEB017 Abstract	Treatment simplification to an atazanavir-containing regimen: impact on patient´s perception of adverse events severity Presented by Jose M Gatell, Spain (TBC) Gatell J.M.1, L'Italien G.2, Wirtz V.3, Odeshoo L.3, Villanueva I.4 1Clinical Institute of Medicine & Dermatology, Infectious Diseases & AIDS Units, Barcelona, Spain, 2Bristol-Myers Squibb, GEOR, Wallingford, United States, 3Bristol-Myers Squibb, Wallingford, United States, 4Bristol-Myers Squibb, GEOR, Braine-l'Alleud, Belgium
MOPEB084 Abstract	Trends in AIDS-defining and non-AIDS-defining cancers among HIV-infected patients: a 20-year study Presented by Nancy Crum-Cianflone, United States (TBC) Crum-Cianflone N.1, Marconi V.1, Weintrob A.1, Ganesan A.1, Barthel R.V.1, Fraser S.1, Agan B.1, Wegner S.1, TriService AIDS Clinical Consortium, Infectious Disease Clinical Research Program 1TriService AIDS Clinical Consortium, Infectious Disease Clinical Research Program (IDCRP), USUHS, Bethesda, United States
MOPEB082 Abstract	Trends in cancer incidence among HIV-infected persons in the United States in the HAART era Presented by Pragna Patel, United States (TBC) Patel P.1, Hanson D.1, Novak R.M.2, Moorman A.1, Tong T.1, Holmberg S.3, Sullivan P.1, Brooks J.T.1, Adult/Adolescent Spectrum of Disease (ASD) and HIV Outpatient Study (HOPS) Investigators 1Centers for Disease Control and Prevention, Division of HIV/AIDS Prevention, Atlanta, GA, United States, 2University of Illinois at Chicago, Chicago, IL, United States, 3Research Triangle Institute (RTI) International, Atlanta, GA, United States
MOPEA083 Abstract	Triple HIV-HCV-GBV-C viral infection: positive effect of GBV-C on immunological, virological and biochemical markers Presented by Giovana Lotici Baggio, Brazil (TBC) Baggio G.L.1, Brunialti M.K.1, Barbosa A.J.1, Alves V.K.1, Lanzara G.1, Granato C.F.H.1 1Federal University of São Paulo, Laboratory of Virology and Immunology I, São Paulo, Brazil
MOPEC010 Abstract	Twelve year trends in HIV-1 prevalence and incidence among adults in rural Rakai District, South Western Uganda Presented by Tom Lutalo, Uganda (TBC) Lutalo T.1, Makumbi F.2, Gray R.3, Serwadda D.2, Nalugoda F.1, Sewankambo N.4, Kigozi G.1, Wawer M.3, Sekasanvu J.1 1Rakai Health Sciences Program, Entebbe, Uganda, 2Institute of Public Health, Makerere University, Kampala, Uganda, 3Johns Hopkins University, Baltimore, United States, 4Makerere Medical School, Kampala, Uganda
MOPEB077 Abstract	Ubisol-AquaTM: coenzyme Q10 prevents antiretroviral toxic neuropathy in an in vitro model Presented by Masqura Mobarok, Australia (TBC) Mobarok M.1, Cherry C.1, Wesselingh S.1, Fain R.2, Hooker D.1 1Burnet Institute, Melbourne, Australia, 2Zymes, New Jersey, United States
MOPEB040 Abstract	Ultrastructural morphology and mitochondrial damage of liver biopsy from HIV/ hepatitis C virus (HCV) co-infected patients being evaluated for HCV therapy Presented by Motoi Matsukura, Canada (TBC) Matsukura M.1, Chu F.S.F.2, Chen J.1, Rietkerk S.3, Gadawska I.M.1, Montessori V.C.4, Cote H.C.F.1, Walker D.C.1 1University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, Canada, 2The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, Vancouver, Canada, 3Immunodeficiency Clinic, St Paul’s Hospital, Vancouver, Canada, 4BC Centre for Excellence in HIV/AIDS, Vancouver, Canada
MOPEA029 Abstract	Update on three elite long term non progresors and the donor in the sydney blood bank cohort (SBBC) after 23-26 years of infection with a nef-deleted/LTR attenuated HIV virus Presented by Jennifer Learmont, Australia (TBC) Learmont J.1, Dyer W.2, Gorry P.3, Churchill M.3, Sullivan J.2 1Australian Red Cross Blood Service, HIV Epidemiology Unit, Sydney, Australia, 2Australian Red Cross Blood Service, Research and Business Development, Sydney, Australia, 3Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Australia
MOPEB070 Abstract	Urinary abnormalities (other than proteinuria) on screening of HIV infected outpatients: implications regarding management Presented by Francois Venter, South Africa Fabian J.1, Naicker S.1, Venter F.2, Baker L.3 1University of Witwatersrand, Johannesburg Hospital, Division of Nephrology, Johannesburg, South Africa, 2HIV Clinic, Johannesburg Hospital, Reproductive Health and Research Unit, University of the Witwatersrand, Johannesburg, South Africa, 3Amayeza Drug Information Centre, Johannesburg Hospital, South Africa
MOPEA018 Abstract	Urokinase-type plasminogen activator (uPA) inhibition of HIV-1 replication in mononuclear phagocytes is dependent upon vitronectin-mediated cell adhesion Presented by Massimo Alfano, Italy (TBC) Alfano M.1, Elia C.1, Sidenius N.2, Blasi F.3, Poli G.1 1Scientific Institute San Raffaele, Immunology and Infectious Diseases Department, Milan, Italy, 2Istituto Firc di Oncologia Molecolare (IFOM), Milan, Italy, 3Scientific Institute San Raffaele, Molecular Biology and Functional Genomics, Milan, Italy
MOPEB007 Abstract	Use of the ELISpot assay to detect abacavir- and nevirapine-induced IFN-g responses in PBMC from HIV-infected patients with abacavir or nevirapine hypersensitivity reactions Presented by Niamh Keane, Australia (TBC) Keane N.1, Lucas A.1, Netto J.1, Almeida C.-A.1, Martin A.1, Marriott D.2, Kelleher A.2, Phillips E.3, Nolan D.1, Simon M.1 1Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Perth, Australia, 2St Vincents Hospital, Sydney, Australia, 3Centre for Pharmacology and Infectious Diseases, Royal Perth Hospital and Murdoch University, Perth, Australia
MOPEA094 Abstract	Use of two commercial interferon-gamma assays for detection of tuberculosis infection among HIV/AIDS patients in Bulgaria Presented by Roumiana Markova, Bulgaria (TBC) Markova R.1, Todorova Y.1, Drenska R.1, Terzieva V.1, Elenkov I.2, Yankova M.2 1National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria, 2Infectious Diseases Hospital 'Prof. I. Kirov', Sofia, Bulgaria
MOPEB103 Abstract	Utility of bone marrow biopsy in the diagnosis of fever of unknown origin in patients with HIV/AIDS histopathology analysis of 429 biopsy samples Presented by Norberto Trione, Argentina (TBC) Trione N.1, Santoro J.1, Risso D.1, Corti M.1, Santoro S.1, Schtirbu R.1 1Hospital F. J. Muñiz, Capital Federal, Argentina
MOPEA032 Abstract	Viral genetic determinants of nonprogressive HIV-1 subtype C infection in antiretroviral drug naïve children Presented by Maria A. Papathanasopoulos, South Africa (TBC) Tzitzivacos D.B.1, Tiemessen C.T.2, Meyers T.M.3, Kuhn L.4, Stevens W.S.1, Papathanasopoulos M.A.1 1University of the Witwaterstand Medical School, Molecular Medicine and Haematology, Johannesburg, South Africa, 2National Institute for Communicable Diseases, Cell Biology, AIDS Unit, Johannesburg, South Africa, 3Chris Hani Baragwanath Hospital, Perinatal Unit, Johannesburg, South Africa, 4Mailman School of Science, Columbia University, Department of Epidemiology, New York, United States
MOPEB014 Abstract	Virologic suppression after hyperlactataemia- related treatment interruption in an African setting Presented by Lerato Mohapi, South Africa (TBC) Laher F.1, Moodley N.1, Maphutha M.1, McIntyre J.1, Mohapi L.1 1Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa
MOPEB052 Abstract	Virological features that alter HBV viral replication in HIV coinfected patients Presented by Lucila Cassino, Argentina (TBC) Cassino L.1, Laufer N.2, Moretti F.1, Bouzas M.B.3, Fernandez S.3, Pérez H.2, Cahn P.2, Salomón H.1, Quarleri J.1 1Argentinean National Reference Center for AIDS, Microbiology, Capital Federal, Argentina, 2Hospital Juan A Fernandez, Infectious Diseases Unit, Buenos Aires, Argentina, 3Hospital Francisco J Muñiz, Virology Unit, Buenos Aires, Argentina
MOPEC039 Abstract	What is the role of community advocacy in future pre-exposure prophylaxis (PrEP) research? Presented by Yasmin Halima, United States (TBC) Halima Y.1, Kort R.2 1International AIDS Society (IAS), New York, United States, 2International AIDS Society (IAS), Geneva, Switzerland
MOPEC038 Abstract	Willingness to participate in a HIV pre-exposure prophylaxis efficacy trial among high risk men who have sex with men in the Andean region Presented by Javier Ricardo Lama, Peru (TBC) Lama J.R.1, Guanira J.1, Goicochea P.1, Segura P.1, Peinado J.1, Montoya O.2, Sanchez J.1, Grant R.M.3 1Asociacion Civil Impacta Salud y Educacion, Lima, Peru, 2Fundacion Ecuatoriana Equidad, Guayaquil, Ecuador, 3Gladstone Institute of Virology and Immunology, University of California San Francisco, San Francisco, United States
MOPEC017 Abstract	Eleven year trend in seroprevalence of HIV among blood donors in a tertiary level hospital in Ethiopia Presented by Afework Kassu, Ethiopia (TBC) Kassu A.1, Tessema B.2, Mulu A.1, Yismaw G.1, Moges F.1, Mengistu G.3, Aseffa A.4 1University of Gondar, Department of Microbiology and Parasitology, Gondar, Ethiopia, 2University of Gondar, Department of Medical Laboratory Technology, Gondar, Ethiopia, 3Addis Ababa University, Internal Medicine, Addis Ababa, Ethiopia, 4Armauer Hansen Research Institute, Addis Ababa, Ethiopia
MOPEA052 Abstract	Elvitegravir (GS-9137/JTK-303), an HIV-1 integrase inhibitor, has additive to synergistic interactions with other antiretroviral drugs in vitro Presented by Damian McColl, United States (TBC) Ledford R.1, Margot N.1, Miller M.1, McColl D.1 1Gilead Sciences, Inc, Foster City, CA, United States
MOPEA063 Abstract	Emerging cases of HIV resistance virus amongst children in a resource-limited treatment centre in Trinidad and Tobago Presented by Nosa Omo-Igbinomwanhia, Trinidad and Tobago Downes A.1, Omo-Igbinomwanhia N.2 1Cyril Ross (SVP) Nursery, Tuanpuna, Trinidad and Tobago, 2Cyril Ross (SVP) Nursery, for HIV/AIDS Children, Tuanpuna, Trinidad and Tobago
MOPEB099 Abstract	Epidemiological features and clinical impact of HTLV-2 infection in Spain Presented by Carlos Toro, Spain Toro C.1, Blanco F.1, Aguilera A.2, García-Gascó P.1, Caballero E.3, Rodríguez C.4, Tuset C.5, Ortiz de Lejarazu R.6, Eiros J.6, Rodés B.1, Calderón E.7, Rodríguez-Iglesias M.8, Santana E.9, Benito R.10, Álvarez P.11, Ramos J.M.12, García J.13, Gómez-Hernando C.14, Dronda F.15, Amor A.16, Soriano V.1, HTLV-1/2 Spanish Study Group 1Hospital Carlos III, Infectious Diseases, Madrid, Spain, 2Complexo Hospitalario Universitario, Microbiology, Santiago, Spain, 3Hospital Vall d'Hebron, Microbiology, Barcelona, Spain, 4Centro Sandoval, Madrid, Spain, 5Hospital General Universitario, Clinical Analyses, Valencia, Spain, 6Hospital Clínico, Microbiology, Valladolid, Spain, 7Hospital Virgen del Rocío, Internal Medicine, Seville, Spain, 8Hospital de Puerto Real, Microbiology, Cadiz, Spain, 9Hospital Universitario Insular, Microbiology, Las Palmas, Spain, 10Hospital Universitario Lozano Blesa, Microbiology, Zaragoza, Spain, 11Complejo Hospitalario, Microbiology, Pontevedra, Spain, 12Hospital General, Internal Medicine, Elche, Spain, 13Hospital Cristal-Piñor, Microbiology, Orense, Spain, 14Hospital Virgen de la Salud, Microbiology, Toledo, Spain, 15Hospital Ramón y
MOPEA085 Abstract	Epidemiology of hepatitis B virus co-infection among HIV infected patients in Lagos, Nigeria Presented by Taiwo Modupe Oyesile-Balogun, Nigeria (TBC) Oyesile-Balogun T.M.1 1Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria, Haematology, Lagos, Nigeria
MOPEC013 Abstract	Epidemiology of the human immunodeficiency virus (HIV) in Lithuania: 19 year surveillance result Presented by Saulius Caplinskas, Lithuania Strujeva O.1, Caplinskas S.2 1Lithuanian AIDS Centre, Vilnius, Lithuania, 2Lithuanian AIDS Centre, Director, Vilnius, Lithuania
MOPEC005 Abstract	Estimated HIV incidence and diversity among men who have sex with men (MSM) in VCTs of Rio de Janeiro State, Brazil Presented by Carlos Augusto Velasco de Castro, Brazil (TBC) Velasco de Castro C.A.1, Grinsztejn B.2, Veloso V.2, Bastos F.I.3, Pilotto J.H.4, Friedman R.2, Moreira R.I.2, Morgado M.G.5 1IOC/IPEC/IFF-Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, 2IPEC-Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, 3CICT - Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, 4IPEC-Oswaldo Cruz Foundation, Hospital Geral de Nova Iguaçu, Rio de Janeiro, Brazil, 5IOC-Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
MOPEC027 Abstract	Ethnic and racial varaince in rationale for HIV testing in a large population sample: findings from the United States National Health Interview survey Presented by Laurens Holmes Jr, United States Holmes Jr. L.1, Monjok E.1, Ogungbade G.1, Ward D.2, Essien E.J.1 1University of Houston, Institute of Community Health, Houston, United States, 2University of Texas, MD Anderson Cancer Center, Houston, United States
MOPEA095 Abstract	Evaluating the routine reporting of the burden of HIV-tuberculosis co-infection in tuberculosis treatment centres in the Adamawa province, Cameroon Presented by Edie Alain Kemenang, Cameroon (TBC) Kemenang E.A.1, Ndikum V.N.2 1Provincial Delegation of Public Health, Provincial Unit for Tuberculosis Control, Ngaoundere, Cameroon, 2Faculty of Medicine & Biomedical Sciences, University of Yaounde 1, Cameroon, Yaoundé, Cameroon
MOPEA037 Abstract	Evaluation of immune activation measured by CD38 and HLA-DR expression on T and B lymphocytes of HIV-1-infected children Presented by Leandro Fagundes Tarosso, Brazil (TBC) Tarosso L.F.1, Hong M.A.1, Ueda M.1 1Institute Adolfo Lutz, Division of Medical Biology, São Paulo, Brazil
MOPEB062 Abstract	Evaluation of liver damage in HIV-1-positive patients on antiretroviral therapy with chronic transaminases elevation of unknown origin (The HEALTH study) Presented by Marc-Antoine Valantin, France (TBC) Valantin M.-A.1, Ingiliz P.2, Charlotte F.3, Dominguez S.1, Simon A.4, Tubiana R.1, Duvivier C.2, Kirstetter M.1, Benhamou Y.2, Katlama C.1 1Pitié-Salpêtrière hospital, Infectious diseases department, Paris, France, 2Pitié-Salpêtrière hospital, Hepato-gastroenterology department, Paris, France, 3Pitié-Salpêtrière hospital, Anatomopathology department, Paris, France, 4Pitié-Salpêtrière hospital, Internal Medecine department, Paris, France
MOPEA049 Abstract	Expanded access to HAART: A powerful strategy to curb the growth of the HIV epidemic and costs Presented by Viviane D. Lima, Canada (TBC) Lima V.D.1, Johnson K.2, Hogg R.S.1, Levy A.R.2, Harrigan P.R.1, Montaner J.S.G.1 1British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 2University of British Columbia, Vancouver, Canada
MOPEA017 Abstract	Expression of RNA and DNA sensing Toll-like receptors in dendritic cell subsets and relevance to co-infection with HIV and HSV Presented by Kerrie Dunstan, Australia (TBC) Dunstan K.1, Donaghy H.1, Marsden V.1, Cunningham A.1 1Westmead Millennium Institute, Centre for Virus Research, Sydney, Australia
MOPEC043 Abstract	Factors associated poor follow-up to HIV post-exposure prophylaxis Presented by James Scott, United States Scott J.1, Bolan R.2 1Western University of Health Sciences, Pharmacy Practice, Pomona, United States, 2LA Gay & Lesbian Center, Jeffrey Goodman Clinic, Los Angeles, United States
MOPEB097 Abstract	Factors associated to coccidian parasites infection at a public hospital in Lima, Peru Presented by Omayra Chincha Lino, Peru (TBC) Chincha Lino O.1, Bernabe A.2, Soto L.1, Samalvides F.3, Terashima A.1, Gotuzzo E.1 1Universidad Peruana Cayetano Heredia, Instituto de Medicina Tropical Alexander Von Humboldt, Lima, Peru, 2Universidad Peruana Cayetano Heredi, Unidad de Epidemiología, ETS, VIH/SIDA. Facultad de Salud Publica y Administración., Lima, Peru, 3Universidad Peruana Cayetano Heredia, Insituto de Medicina Tropical Alexander Von Humboldt, Lima, Peru
MOPEC021 Abstract	Factors associated with high-risk behavior among sexually active HIV-infected men and their stable partners in Brazil Presented by Mark D. C. Guimarães, Brazil (TBC) Guimarães M.D.C.1, Grinsztejn B.2, Chin-Hong P.V.3, Campos L.N.1, Gomes V.R.4, Melo V.H.1, Pilloto J.H.5, Carmo R.A.6, Palefsky J.M.3 1Federal University of Minas Gerais, Belo Horizonte, MG, Brazil, 2Evandro Chagas Research Institute/Fiocruz, Rio de Janeiro, Brazil, 3University of California, San Francisco, United States, 4Federal University of Rio de Janeiro, Rio de Janeiro, Brazil, 5Nova Iguaçu Hospital, Nova Iguaçu, RJ, Brazil, 6Eduardo de Menezes Hospital, Belo Horizonte, MG, Brazil
MOPEA097 Abstract	Factors associated with the severity of malaria episodes in patients enrolled in the French Hospital Database on HIV (ANRS CO4) Presented by Christian Mouala, France (TBC) Mouala C.1, Houze S.2, Guiguet M.1, Abbout P.3, Pialoux G.4, Viget N.5, Costagliola D.1, Matheron S.6 1U720 INSERM et Université Pierre et Marie Curie, Epidemiologie clinique et therapeutique de l'infection a VIH, Paris 13, France, 2Hôpital Bichat-Claude Bernard, Service de parasitologie, Paris, France, 3Hôpital Charles Nicolle, Service des Maladies Infectieuses et Tropicales, Rouen, France, 4Hôpital Tenon, Service des Maladies Infectieuses et Tropicales, Paris, France, 5Centre Hospitalier de Tourcoing, Service universitaire des maladies infectieuses et du voyageur, Tourcoing, France, 6Hôpital Bichat-Claude Bernard, Service des Maladies Infectieuses et Tropicales, Paris, France
MOPEB090 Abstract	Factors influencing thymic function in patients candidates to autologous stem cell transplantation Presented by Cecilia Simonelli, Italy (TBC) Simonelli C.1, Pratesi C.1, Zanussi S.1, Talamini R.1, Rupolo M.1, Bortolin M.T.1, Abbruzzese L.1, Gattei V.1, Spina M.1, Michieli M.1, De Paoli P.1, Tirelli U.1 1National Cancer Institute, Aviano (PN), Italy
MOPEB083 Abstract	Fifteen years of malignancies in HIV positive patients: increasing proportion of non HIV-associated tumors Presented by Fulvio Crippa, Italy (TBC) Crippa F.1, Ceserani N.1, Ratti D.1, Cinque P.1, Bossolasco S.1, Castagna A.1, Fumagalli L.L.1, Galli L.1, Lazzarin A.2 1San Raffaele Hospital, Infectious Diseases, Milan, Italy, 2Vita Salute University-San Raffaele Hospital, Infectious Diseases, Milan, Italy
MOPEB094 Abstract	Food security of people living with HIV in the Sydney metropolitan area, Australia Presented by Antoinette Ackerie, Australia (TBC) Ackerie A.1, Houtzager L.2, George C.3, Sadler S.2, Brown K.4, Gayford M.2 1Royal Prince Alfred Hospital, Nutrition and Dietetics, Sydney, Australia, 2Albion Street Centre, Nutrition Development Division, Sydney, Australia, 3Redfern Community Centre, Nutrition and Dietetics, Albert St, Redfern, Sydney, Australia, 4St Vincents Hospital, Nutrition and Dietetics, Sydney, Australia
MOPEB102 Abstract	Frequency of parasitic intestinal infections in HIV-infected and non-HIV infected patients in Lima, Peru Presented by Omayra Chincha, Peru (TBC) Chincha O.1, Bernabe A.2, Soto L.3, Salmavides F.1, Terashima A.1, Gotuzzo E.1 1Universidad Peruana Cayetano Heredia, Instituto de Medicina Tropical Alexander von Humboldt, Lima, Peru, 2Universidad Peruana Cayetano Heredia, Unidad de Epidemiología, ETS, VIH/SIDA. Facultad de Salud Publica y Administración, Lima, Peru, 3Universidad Peruana Cayetano Heredia, Instituto de Medicina Tropical, Lima, Peru
MOPEA034 Abstract	Functional analysis of R5X4 HIV-1 Envs derived from brain and lymphoid tissues of individuals with AIDS Presented by Lachlan Gray, Australia (TBC) Gray L.1, Churchill M.2, Cowley D.2, Sterjovski J.1, Ellett A.1, Wesselingh S.2, Gabuzda D.3, Gorry P.1 1The Macfarlane Burnet Institute for Medical Research and Public Health, HIV-1 Molecular Pathogenesis, Melbourne, Australia, 2The Macfarlane Burnet Institute for Medical Research and Public Health, Neurovirology, Melbourne, Australia, 3Dana-Farber Cancer Institute, Boston, United States
MOPEA007 Abstract	Functional analysis of Vpr mutants identified in HIV+ patient cohorts Presented by Eleanor M. Hitchen, Australia (TBC) Hitchen E.M.1, Wang B.1, Saksena N.1, Piller S.C.1 1Westmead Millennium Institute, Centre for Virus Research, Westmead, Australia
MOPEC030 Abstract	Funding an expanded prevention toolbox: recent funding for new HIV prevention interventions research and development Presented by Mitchell Warren, United States (TBC) Deshmukh V.1, Fisher K.1, Warren M.1, Finley B.2, Harrison P.2, Lamourelle G.3, Vuthoori S.3 1AIDS Vaccine Advocacy Coalition, New York, United States, 2Alliance for Microbicide Development, Silver Springs, United States, 3International AIDS Vaccine Initiative, New York, United States
MOPEA090 Abstract	GBV-C persistence does not require CD4+ T cell preservation, and GBV-C viral load (VL) is weakly inversely related to HIV VL Presented by Jack T Stapleton, United States (TBC) Barnes A.1, Allen J.B.2, Klinzman D.2, Zhang Z.3, Chaloner K.3, Stapleton J.T.2 1University of Iowa, Internal Medicine, Iowa City, United States, 2Iowa City VA Medical Center and the University of Iowa, Internal Medicine, Iowa City, United States, 3University of Iowa College of Public Health, Biostatistics, Iowa City, United States
MOPEB001 Abstract	Genetic characterization of patients with MHC class I mediated abacavir hypersensitivity reaction Presented by Elizabeth Phillips, Australia (TBC) Phillips E.1, Rauch A.2, Nolan D.3, Martin A.3, Almeida C.-A.3, Knowles S.4, Shear N.4, Cavassini M.5, Harrigan R.6, Montaner J.6, Keane N.3, Laird R.3, Lucas A.3, Mallal S.3 1Centre for Pharmacology & Infectious Diseases, Murdoch University, Royal Perth Hospital, Perth, Australia, 2University Hospital, Division of Infectious Diseases, Berne, Switzerland, 3Centre for Clinical Immunology & Biomedical Statistics, Royal Perth Hospital, Murdoch University, Perth, Australia, 4Sunnybrook Health Sciences Centre, Toronto, Canada, 5Division des maladies infectieuses, CHUV, Lausanne, Switzerland, 6British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada
MOPEA076 Abstract	Growth of a subtype A and a subtype C HIV-1 strain in a cervical tissue explant model Presented by Diana Huang, United States (TBC) Huang D.1, Lurain N.1, Natarajan V.1, Morack R.1, Fitzgibbon J.2, Bremer J.1 1Rush University Medical Center, Department of Immunology/Microbiology, Chicago, IL, United States, 2NIH/NIAID/DAIDS, Bethesda,MD, United States
MOPEA072 Abstract	Hepatic effects of atazanavir plus ritonavir (ATV/r)-based combinations in patients with hepatitis virus coinfection: relationship with pre-existing liver damage Presented by JUAN ANTONIO PINEDA, Spain (TBC) Abdel-Kader L.1, Santos J.2, Rivero A.3, Lozano F.4, Palacios R.2, Camacho A.3, Pineda J.A.4 1Hospital De Valme, Hospital Pharmacy, Seville, Spain, 2Hospital Virgen De La Victoria, Infectious Diseases, Malaga, Spain, 3Hospital Reina Sofia, Infectious Diseases, Cordoba, Spain, 4Hospital De Valme, Infectious Diseases, Seville, Spain
MOPEB051 Abstract	Hepatitis B co-infection in HIV positive patients in Hong Kong Presented by Huizhen Li, Hong Kong (TBC) Li H.1, Lee S.1, Chu S.1, Wu J.1, Li P.C.2, Wong K.3, Lee M.2, Tse C.3, Sung J.1 1The Chinese University of Hong Kong, Stanley Ho Centre for Emerging Infectious Diseases, Hong Kong, Hong Kong, 2Queen Elizabeth Hospital, Kowloon, Hong Kong, Hong Kong, 3Integrated Treatment Centre, Department of Health, Hong Kong, Hong Kong
MOPEB046 Abstract	Hepatitis C biral kinetics during treatment with weekly versus twice weekly peg IFN-alpha-2a in HIV/HCV co-infected patients Presented by Michael Polis, United States (TBC) Polis M.1, Sachau W.1, O'Shea M.1, Rehm C.1, Koratich C.1, Masur H.2, Kottilil S.1 1NIH/NIAID/LIR, Bethesda, United States, 2CCMD/CC/NIH, Bethesda, United States
MOPEA046 Abstract	HERV – K superfamily envelope glycoprotein make holes in immune repertoire during ontogeny. This leads to poor immune responses to HIV -1: immunoinformatics approach Presented by Muriira Karau, Kenya (TBC) Karau M.1 1Egerton University, Biochemistry and Molecular Biology, Nairobi, Kenya
MOPEB078 Abstract	High burden of neurological disease in HIV positive inpatients within the Asia Pacific (AP) region: the APNAC study Presented by Edwina J Wright, Australia (TBC) Wright E.J.1, Brew B.J.2, Arayawichanont A.3, Samintharapanya K.4, Kongsaengdao S.5, Lal L.6, Lewis J.7, Imran D.8, Robertson K.9, Saphonn V.10, Sarim C.11, Huffam S.E.11, Li P.12, Lim M.13, Lun W.H.14, Kamarulzaman A.15, Tau G.16, Ty Ali S.17, Kishore K.18, Bain M.2, Dwyer R.19, McCormack G.7, Hellard M.E.7, Cherry C.L.7, McArthur J.C.20, Wesselingh S.L.21 1The Alfred Hospital, Melbourne, Infectious Diseases, Victoria, Australia, 2St Vincent’s Hospital, Sydney, Australia, 3Sappasithiprasong Hospital, Ubon Ratchathani, Thailand, 4Lampang Hospital, Lampang, Thailand, 5Rajavithi Hospital, Bangkok, Thailand, 6The Macfarlane Burnet Institute for Medical Research & Public Health Ltd., Melbourne, Australia, 7Burnet Institute, Melbourne, Australia, 8University of Indonesia, Jakarta, Indonesia, 9UNC-Chapel Hill, North Carolina, United States, 10National Institute of Public Health, Phnom Penh, Cambodia, 11Ministry of Health, Cambodia, Phnom Penh, Cambodia, 12Queen Elizabeth Hospital Hong Kong, Hong Kong, Hong Kong, 13Burnet Institute, Melbouorne, Australia, 14Ditan Hospital, Beijing, China, 15University of Malaya Medical Centre, Kuala Lumpur, Malaysia, 16Port Moresby General
MOPEA045 Abstract	High frequency of HIV-1 dual infections in individuals with double transmission risk in Buenos Aires, Argentina Presented by Guadalupe Andreani, Argentina (TBC) Andreani G.1, Ambrosioni Czyrko J.C.2, Bouzas M.B.3, Fernández Giuliano S.3, Benetucci J.2, Carr J.K.4, Martínez Peralta L.1 1National Reference Center for AIDS, University of Buenos Aires, Buenos Aires, Argentina, 2Infectious Diseases Department, FJ Muñiz Infectious Diseases Hospital, Buenos Aires, Argentina, 3Virology Unit, Infectious Diseases 'FJ Muñiz' Hospital, Buenos Aires, Argentina, 4Epidemiology Dept, Institute of Human Virology, University of Maryland Biotechnology Institute, Baltimore, United States
MOPEB107 Abstract	High prevalence of multiple HPV genotypes among HIV-1-infected Brazilian women Presented by Mark D. C. Guimarães, Brazil Melo V.1, Araújo A.2, Corrêa C.1, del Castillo D.3, Carvalho N.3, Faria I.1, Oliveira H.4, Teixeira N.2, Lodi C.4, Ceccato Jr B.4, Lima M.I.5, Oliveira I.6, Alves A.7, Souza T.1, Machado C.1, Rodrigues C.2, Guimarães M.1, Research Group on Women and HIV 1Universidade Federal de Minas Gerais, Faculdade de Medicina, Belo Horizonte, Brazil, 2CTR-DIP Orestes Diniz, Prefeitura Municipal, Belo Horizonte, Brazil, 3Universidade Federal de Minas Gerais, NUPAD - Faculdade de Medicina, Belo Horizonte, Brazil, 4Faculdade de Ciências Médicas de Minas Gerais, Belo Horizonte, Brazil, 5PAM Sagrada Família, Prefeitura Municipal, Belo Horizonte, Brazil, 6Prefeitura Municipal, Barbacena, Brazil, 7Prefeitura Municipal, Conselheiro Lafaiete, Brazil
MOPEA079 Abstract	High proportion of mixed HBV genotypes detected in a cohort of HIV/HBV co-infected patients Presented by Margaret Littlejohn, Australia (TBC) Littlejohn M.1, Ayres A.1, Revill P.1, Colledge D.1, Yuen L.1, Matthews G.2, Dore G.2, Lewin S.3, Sasaduesz J.4, Thio C.5, Locarnini S.1 1Victorian Infectious Diseases Reference Laboratory, North Melbourne, Australia, 2National Centre in HIV Epidemiology and Clinical Research, Sydney, Australia, 3Monash University, Department of Medicine, Melbourne, Australia, 4Royal Melbourne Hospital, Victorian Infectious Diseases Service, Melbourne, Australia, 5Johns Hopkins University, Department of Medicine, Baltimore, United States
MOPEA016 Abstract	Higher type 1 interferon levels in plasma could support NK cells activity in asymptomatic HIV-2 than in HIV-1 individuals Presented by Samuel Victor Nuvor, Gambia (TBC) Nuvor S.V.1, Whittle H.1, Rowland-Jones S.1, Crozier S.1, Avieka A.1, Jaye A.1 1Medical Research Council Laboratories, Viral Diseases, Banjul, Gambia
MOPEB010 Abstract	History of drug allergy associated with nevirapine toxicity among AIDS patients with low baseline CD4 count Presented by Wirach Maek-a-nantawat, Thailand (TBC) Maek-a-nantawat W.1, Tansuphaswadikul S.2, Eindani Aung S.1, Phonrat B.1, Aramaki M.1, Kaewkungwal J.3, Pittisuttithum P.1 1Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, 2Bamrasnaradura Institute, Ministry of Public Health, Nonthaburi, Thailand, 3Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
MOPEA098 Abstract	HIV and malaria co-infection in pregnancy: a comparative study of incidence and determinant Presented by Franklin Udah, Nigeria (TBC) Udah F.1, Nwajei F.2 1Anti AIDS Club, University of Lagos, Nigeria, 1, Nigeria, 2Lagos University Teaching Hospital, Lagos, Nigeria
MOPEA050 Abstract	HIV dynamics with multiple infections of cells and recombination Presented by Gajendra Suryawanshi, India (TBC) Suryawanshi G.1, Dixit N.1 1Indian Institute of Science, Department of Chemical Engineering, Bangalore, India
MOPEA005 Abstract	HIV genotyping in the Free State of South Africa Presented by Wilhelmina van den Heever, South Africa (TBC) van den Heever W.1 1Central University of Technology, School of Health Technology, Bloemfontein, South Africa
MOPEC002 Abstract	HIV incidence among Royal Thai Army conscripts Presented by Khunakorn Kana, Thailand (TBC) Kana K.1, Tabprasit S.1, Chaitaveep P.1, Tienamporn P.2, Chuenchitra T.1 1Armed Forces Research Institute of Medical Sciences, Royal Thai Army, Bangkok, Thailand, 2Army Institute of Pathology, Bangkok, Thailand
MOPEC007 Abstract	HIV incidence using BED testing among clients attending anonymous HIV testing site in Bangkok, Thailand Presented by Tanakorn Apornpong, Thailand (TBC) Apornpong T.1, Pankum T.1, Sirivichayakul S.1, Phanuphak N.1, Cunningham P.2, Stein E.3, Kaldor J.4, Page-Shafer K.5, Phanupak P.1 1Thai Red Cross AIDS Research Centre, Bangkok, Thailand, 2St Vincent's Hospital, Centre for Immunology & St Vincent’s Research Campus, Sydney, Australia, 3University of California, Center for AIDS Prevention Studies, San Francisco, United States, 4University of New South Wales, National Centre in HIV Epidemiology and Clinical Research, Sydney, Australia, 5University of California San Francisco, Center for AIDS Prevention Studies, San Francisco, United States
MOPEC018 Abstract	HIV prevalence is rising among men who have sex with men, Beijing: results of three consecutive respondent-driven sampling surveys, 2004-2006 Presented by Xiaoyan Ma, China (TBC) Ma X.1, Zhang Q.2, He X.1, Zhao J.3, Sun W.1, Yue H.1, Chen S.4, Raymond H.F.4, Li Y.1, Xu M.1, Du H.5, Sabin K.6, McFarland W.7 1Beijing Center for Disease Prevention and Control, Division of STDs/AIDS Prevention and Control, Beijing, China, 2Beijing Center for Disease Prevention and Control, DDivision of STDs/AIDS Prevention and Control, Beijing, China, 3Jiangsu Center for Disease Control and Prevention, Nanjing, Jiangsu, China, 4San Francisco Department of Public Health, San Francisco, CA, United States, 5The Male Gender Health Education Institution, Beijing, China, 6US Centers for Disease Control, Atlanta, GA, United States, 7San Francisco Department of Public Health; University of California, San Francisco, United States
MOPEC024 Abstract	HIV risk and health care seeking behaviors among commercial sex workers (CSW), using respondent driven sampling (RDS) in Porto Alegre, Brazil Presented by Kimberly Page-Shafer Carvalho F.T.1, Germany C.1, Chen S.2, Barbosa L.H.R.1, Siqueira A.C.S.1, Ramos M.C.1, Page-Shafer K.3 1Centro de Estudos de Aids e DST do Rio Grande do Sul, Porto Alegre, Brazil, 2University of California in San Francisco, San Francisco, United States, 3University of California in San Francisco, Center for Aids Prevention Studies - Department of Medicine - Institute for Global Health, San Francisco, United States
MOPEC001 Abstract	HIV RNA detection for the diagnosis of incident HIV infection in a sexually-transmitted diseases clinic in the District of Columbia, USA Presented by Mark Parta, United States (TBC) Parta M.1, Hu Z.2, Sankar S.3, Rosenberg A.1, Follmann D.2, Polis M.4 1Clinical Research Directorate, SAIC-Frederick, Inc., Frederick, MD, United States, 2Biostatistics Research Branch, NIH/NIAID/DCR, Bethesda, MD, United States, 3District of Columbia, Department of Health, Washington, DC, United States, 4Collaborative Clinical Research Branch, NIH/NIAID/DCR, Bethesda, MD, United States
MOPEC020 Abstract	HIV testing and an information-motivation (IM) intervention in South Indian truck drivers in Andhra Pradesh Presented by Gurcharon Salujah, India Schneider J.1, Kassen M.2, Dinaker M.3, Laumann E.4, Oruganti G.3, Dass S.5, Salujah G.3, Chundi V.3, Vijayraghavan K.3, Kumar V.3, Mayer K.6, Yeldandi V.3 1Lifespan/Tufts/Brown, Center for AIDS Research, Chicago, United States, 2University of Illinois, Chicago, United States, 3SHARE/MediCiti, MediCiti Immunology and Infectious Diseases Research Institute, Shamirpet, India, 4University of Chicago, Sociology, Chicago, United States, 5SHARE/MediCiti, Microbiology, Shamirpet, India, 6Lifespan/Tufts/Brown Center for AIDS Research, Providence, United States
MOPEC040 Abstract	HIV vaccine acceptability among female public clinic attendees in Nairobi: the impact of vaccine characteristics Presented by Peter A. Newman, Canada (TBC) Newman P.A.1, Meghani H.2, Maingi I.3, Wandaka H.3 1University of Toronto, Faculty of Social Work, Toronto, ON, Canada, 2McMaster University, Hamilton, ON, Canada, 3University of Nairobi, Nairobi, Kenya
MOPEC037 Abstract	HIV vaccine trial concerns among persons who screen in but decline to enroll: a mixed-method investigation Presented by Peter A. Newman, Canada Newman P.A.1, Daley A.1, Ellinor D.2, Logie C.1, Loutfy M.3 1University of Toronto, Faculty of Social Work, Toronto, ON, Canada, 2Canadian Immunodeficiency Research Collaborative, Toronto, ON, Canada, 3University of Toronto; Canadian Immunodeficiency Research Collaborative, Toronto, ON, Canada
MOPEC009 Abstract	HIV/STIs incidence and behavioral changes within six-month follow-up of female sex workers in Yunnan Province, China Presented by Ning Wang, China (TBC) Wang N.1, Xu J.J.1, Lu L.2, Ma J.G.3, Wang H.B.1, Michelle W.1, Wu Z.L.4, Zheng X.W.1 1National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Division of Epidemiology, Beijing, China, 2Yunnan Province Center for Disease Control and Prevention, Kunming, China, 3Kaiyuan City Center for Disease Control and Prevention, Kunming, China, 4Peking Union Medical College, Department of Epidemiology, Devision of Epidemiology, Beijing, China
MOPEA010 Abstract	HIV-1 and HIV-2: total DNA and 2LTR circular DNA in the early phase of infection in vitro quantification by real time PCR using a combined HIV-1+ HIV-2 plasmid Presented by François Simon, France (TBC) Gueudin M.1, Plantier J.C.1, Damond F.2, Simon F.3 1CHU Charles Nicolle, virology, Rouen, France, 2CHU Bichat, Virology, Paris, France, 3CHU Saint Louis, Microbiology, Paris, France
MOPEA027 Abstract	HIV-1 Nef interferes with DC/NK crosstalk Presented by Marina Viora, Italy (TBC) Viora M.1, Napolitano A.1, Sanchez M.2, Giordani L.1, Mattioli B.1, Quaranta M.G.1 1Istituto Superiore di Sanità, Department of Drug Research and Evaluation, Rome, Italy, 2Istituto Superiore di Sanità, Department of Cell Biology and Neurosciences, Rome, Italy
MOPEA036 Abstract	HIV-1 production and depletion of activated and non-activated cells in human lymphoid tissue ex vivo Presented by jean-Charles grivel, United States (TBC) Biancotto A.1, Lisco A.1, Vanpouille C.1, Margolis L.1, Grivel J.-C.1 1Laboratory of Molecular and Cellular Biophysics, National Institute of Child Health and Human Development, Bethesda, United States
MOPEA039 Abstract	HIV-1 restricting APOBEC proteins associate with a cellular serine/threonine kinase Presented by J.F. Krisko, United States (TBC) Krisko J.F.1, Foster J.L.1, Garcia-Martinez J.V.1 1University of Texas Southwestern Medical Center, Internal Medicine, Dallas, United States
MOPEA008 Abstract	HIV-2 induces NF-κB activation and cyclooxygenase-2 expression in human glial cells: Role in neuronal toxicity Presented by Susana Álvarez, Spain (TBC) Álvarez S.1, Blanco A.2, Kern F.2, Fresno M.1, Muñoz-Fernández M.Á.2 1Centro de Biología Molecular Severo Ochoa, UAM, Madrid, Spain, 2Hospital General Universitario Gregorio Marañón, Madrid, Spain
MOPEB039 Abstract	HIV-HCV coinfected patients have to be screened for hepatic steatosis Presented by Isabelle Poizot-Martin, France (TBC) Poizot-Martin I.1, Benhaim S.1, Drogoul-Vey M.-P.1, Pradel V.2, Vion-Dury F.1, Poluzzi J.-C.3, Gastaut J.A.1 1APHM Hôpital Sainte Marguerite, CISIH SUD Unité Hématologie VIH, Marseille, France, 2APHM Hôpital Sainte Marguerite, Département d'Informatique Médicale, Marseille, France, 3Laboratoire d'Anatomopathologie, Marseille, France
MOPEB003 Abstract	HLA-B*5701 carriage: preliminary result in a Caribbean cohort of HIV-infected patients Presented by SYLVIE ABEL, France (TBC) Abel S.1, Paturel L.2, Pierre-Francois S.1, Bera O.2, Beraud G.1, Liautaud B.1, Cesaire R.2, Cabie A.1 1CHU de Fort-de-France, Infectious Diseases, Fort-de-France, France, 2CHU de Fort-de-France, Virology and Immunology, Fort-de-France, France
MOPEB002 Abstract	How effectively HLA screaning can reduce the early discontinuation of abacavir in real life? Presented by Benoit Trottier, Canada Trottier B.1, Thomas R.1, Nguyen V.K.1, Machouf N.1 1Clinique medicale l'Actuel, Montreal, Canada
MOPEB087 Abstract	HPV DNA screening as an adjunct to standard PAP testing in identifying a subset of HIV+ males at higher risk for developing anal neoplasia - a pilot study Presented by Stephen Berman, United States (TBC) Berman S.1, Kukes G.2, Dacosta-Iyer M.2, Ouyang Y.2, Chapman-Bueno J.3, Horansky E.3, Berman J.4 1VA Long Beach Healthcare System, Infectious Diseases, Orange, United States, 2VA Long Beach Healthcare System, Pathology, Long Beach, United States, 3VA Long Beach Healthcare System, Molecular Diagnostics, Long Beach, United States, 4Northwestern University, Evanston, United States
MOPEB072 Abstract	Human herpesvirus 6: a new emerging pathogen in AIDS patients Presented by Marcelo Corti, Argentina (TBC) Corti M.1, Villafañe M.F.1, Trione N.1, Semorile K.1, Mamanna L.2, Bouzas B.2 1Unit 10, Infectiuos Diseases Hospital “Francisco J. Muñiz”. Buenos Aires, Argentina, Buenos Aires, Argentina, 2Virology Laboratory, Infectiuos Diseases Hospital “Francisco J. Muñiz”, Buenos Aires, Argentina
MOPEA030 Abstract	Human leukocytes antigen – an alleles diversity is critical in HIV/AIDS susceptibility and resistance. Immunoinformatics approach Presented by Muriira Karau, Kenya (TBC) Karau M.1 1Egerton University, Biochemistry and Molecular Biology, Nairobi, Kenya
MOPEB106 Abstract	Human papillomavirus typing in a cohort of HIV-1 infected men in Milan, Italy Presented by Giovanna Orlando, Italy (TBC) Orlando G.1, Tanzi E.2, Beretta R.1, Fasolo M.M.1, Bianchi S.2, Mazza F.1, Rizzardini G.1 1L Sacco Hospital, II Dept Infectious Diseases, Milan, Italy, 2University of Milan, Dept of Public Health, Microbiology and Virology, Milan, Italy
MOPEA096 Abstract	Immune reconstitution syndrome in patients treated for HIV and tuberculosis in Rio de Janeiro Presented by Valeria Rolla, Brazil (TBC) Serra F.1, Hadad D.2, Velasque L.1, Orofino R.1, Morgado M.3, Lourenço C.1, Rolla V.1, IPEC Tuberculosis program 1Fundação Oswaldo Cruz (Fiocruz), Instituto de Pesquisa Clinica Evandro Chagas, Departamento de Doenças Infecciosas, Rio de Janeiro, Brazil, 2Universidade Federal do Espirito Santo, Nucleo de Doenças Infecciosas, Espirito Santo, Brazil, 3Fundação Oswaldo Cruz, Instituto Oswaldo Cruz, Departamento de Imunologia, Rio de Janeiro, Brazil
MOPEB044 Abstract	Immunological progression of HIV in a population of treated HCV co-infected patients Presented by Jill Tolia, United States (TBC) Tolia J.1, Slim J.1, Fallon J.1, Modi C.1, Murphy E.M.1, Smith S.M.1 1St Michael's Medical Center, Infectious Diseases, Newark, United States
MOPEB056 Abstract	Impact of different ART regimens on efficacy and safety of standard HCV treatment in HIV/HCV co-infected patients Presented by Pavel Khaykin, Germany (TBC) Khaykin P.1, Vogel M.2, Voigt E.2, Rockstroh J.2, Carlebach A.3, Lutz T.3, Staszewski S.1 1University of Frankfurt, HIVCENTER, HIV Treatment & Clinical Research Unit, Frankfurt on Main, Germany, 2University Hospital Bonn, Department of Internal Medicine I, Bonn, Germany, 3Private Practice Friedenstrasse, Frankfurt on Main, Germany
MOPEC008 Abstract	Impact of HIV-infection among illegal migrants in Brescia, Italy Presented by Maria Chiara Pezzoli, Italy Carosi G.1, Pezzoli M.C.1, El-Hamad I.1, Scarcella C.2, Indelicato A.2, Speziani F.2, Scolari C.2, Lionetto F.2, Ricci A.1, Grassi E.2, Bergamaschi V.1 1Spedali Civili, Infectious Diseases, Brescia, Italy, 2Azienda Sanitaria Locale, International Health Center, Brescia, Italy
MOPEA081 Abstract	Impact of nationwide hepatitis B vaccination on chronic hepatitis B virus (HBV) infection among HIV-infected patients in a hyperendemic area for HBV infection Presented by Chien-Ching Hung, Taiwan, Province of China (TBC) Sun H.-Y.1, Ko W.-C.2, Wu C.-H.1, Lee H.-C.2, Liu W.-C.1, Sheng W.-H.1, Lo Y.-C.1, Hung C.-C.1 1National Taiwan University Hospital, Internal Medicine, Taipei, Taiwan, Province of China, 2National Cheng-Kung University Hospital, Internal Medicine, Tainan, Taiwan, Province of China
MOPEB034 Abstract	Incidence of adverse events during tuberculosis therapy in patients with and without HIV co-infection Presented by Rafael Laucas Pereira, Brazil Pereira R.L.1, Velasque L.1, Brasil P.E.A.2, Orofino R.1, Costa M.J.M.1, Carvalho M.S.3, Rolla V.C.1 1Fundação Oswaldo Cruz, Instituto de Pesquisa Clínica Evandro Chagas, Rio de Janeiro, Brazil, 2Fundação Oswaldo Cruz, Departamento de Epidemiologia, Rio de Janeiro, Brazil, 3Fundação Oswaldo Cruz, Escola Nacional de Saúde Pública, Rio de Janeiro, Brazil
MOPEB061 Abstract	Incidence of hyperbilirubinemia and jaundice due to atazanavir was higher in a cohort of Hispanic patients Presented by Gustavo Lopardo, Argentina Bissio E.1, Lopardo G.1, Bugarín G.2, Cassetti I.2 1FUNCEI, Buenos Aires, Argentina, 2Helios Salud, Buenos Aires, Argentina
MOPEB008 Abstract	Incidence of nevirapine-associated hypersensitivity reactions is different in patients with prior treatment experience compared to treatment-naïve patients: the ATHENA cohort study Presented by Anouk Marjolein Kesselring, Netherlands (TBC) Wit F.1, Kesselring A.2, Gras L.2, Richter C.3, van der Ende M.4, Brinkman K.5, Lange J.1, de Wolf F.2, Reiss P.1, The Netherlands ATHENA Observational Cohort 1Center for Poverty-Related Communicable Diseases and Academic Medical Center, Department of Infectious Diseases, Tropical Medicine and AIDS, Amsterdam, Netherlands, 2HIV Monitoring Foundation, Amsterdam, Netherlands, 3Rijnstate ziekenhuis, Department of Internal Medicine, Arnhem, Netherlands, 4Erasmus Medical Center, Department of Internal Medicine, Rotterdam, Netherlands, 5Onze Lieve Vrouwe Gasthuis, Department of Internal Medicine, Amsterdam, Netherlands
MOPEB019 Abstract	Incidence of tuberculosis in HIV-seroconverters from different transmission categories in Spain: 1982-2004 Presented by Roberto Muga, Spain (TBC) Muga R.1, Langohr K.1, del Romero J.2, García de Olalla P.3, Quintana M.4, Ruiz I.5, Ferreros I.6, Pérez-Hoyos S.6, Cisneros J.M.7, Sanvisens A.1, del Amo J.8, GEMES (Multicenter Study Group of Spanish Seroconverters) 1Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 2Centro Clínico Sandoval, Madrid, Spain, 3Agencia de Salud Pública de Barcelona, Barcelona, Spain, 4Hospital La Paz, Madrid, Spain, 5Hospital Vall d'Hebrón, Barcelona, Spain, 6Escuela Valenciana de Estudios en Salud (EVES), Valencia, Spain, 7Hospital Virgen del Rocio, Sevilla, Spain, 8Universidad Miguel Hernández, San Juan de Alicante, Spain
MOPEA043 Abstract	Increase of antiretroviral efficiency by NSAIDs: role of MRP-4 Presented by Mª Isabel Clemente, Spain (TBC) Clemente M.I.1, Álvarez S.2, Serramía M.J.1, Muñoz-Fernández M.Á.1 1Hospital General Universitario Gregorio Marañón, Madrid, Spain, 2Centro de Biología Molecular Severo Ochoa, UAM, Madrid, Spain
MOPEA021 Abstract	Increased frequency of CD25+FoxP3+ CD4 T cells in HIV-1 infected patients with low CD4 T cell recovery under ART despite undetectable viremia Presented by Rui S. Soares, Portugal (TBC) Albuquerque A.S.1, Foxall R.B.1, Soares R.S.1, Victorino R.M.M.1, Sousa A.E.1 1Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Imunologia Clínica, Lisboa, Portugal
MOPEB086 Abstract	Increased incidence of skin cancers among HIV-infected persons Presented by Nancy Crum-Cianflone, United States (TBC) Crum-Cianflone N.1, Marconi V.1, Weintrob A.1, Ganesan A.1, Barthel R.V.1, Fraser S.1, Agan B.1, Wegner S.1, TriService AIDS Clinical Consortium, Infectious Disease Clinical Research Program (IDCRP), USUHS 1TriService AIDS Clinical Consortium, Infectious Disease Clinical Research Program (IDCRP), USUHS, Bethesda, United States
MOPEB036 Abstract	Increasing incidence of acute hepatitis C in a cohort of individuals diagnosed with primary HIV Presented by Julie Fox, United Kingdom (TBC) Fox J.1, Thompson E.2, Nastouli E.3, McClure M.2, Muir D.3, Fidler S.2 1Imperial College, Infectious diseases, London, United Kingdom, 2Imperial College, Infectious Diseases, London, United Kingdom, 3St Mary's Hospital, Virology, London, United Kingdom
MOPEB057 Abstract	Influence of liver fibrosis on highly active antiretroviral therapy–associated hepatotoxicity in HIV positive patients Presented by Nicoletta Marino, Italy (TBC) Marino N.1, Lo Caputo S.1, Blè C.1, Pierotti P.1, Mazzotta F.1 1S.M.Annunziata Hospital, Infectious Diseases, Firenze, Italy
MOPEA069 Abstract	Influence of MDR-1 polymorphisms on response to HAART regimen containing indinavir and lopinavir in HIV-1 infected children Presented by Rosa Bologna, Argentina Mangano A.1, Bellusci C.2, Currás V.3, Mecikovsky D.4, Rocco C.2, Bramuglia G.3, Aulicino P.2, Rubio M.3, Bologna R.5, Sen L.2 1Hospital de Pediatría Juan P. Garrahan. AIDS International Training and Research Program at Mount Sinai School of Medicine-Argentina Program, Lab. Biología Celular y Retrovirus, Buenos Aires, Argentina, 2Hospital de Pediatría Juan P. Garrahan, Lab. Biología Celular y Retrovirus, Buenos Aires, Argentina, 3Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Cátedra de Farmacología, Buenos Aires, Argentina, 4Hospital de Pediatría Juan P. Garrahan, Servicio de Infectología, Buenos Aires, Argentina, 5Hospital de Pediatría Juan P. Garrahan. AIDS International Training and Research Program at Mount Sinai School of Medicine-Argentina Program, Servicio de Infectología, Buenos Aires, Argentina
MOPEA002 Abstract	Inhibition of retrovirus release by a late domain peptide Presented by Miranda Xhilaga, Australia Xhilaga M.1, Van Der Meulen J.1, Ellis S.2, Crowe S.3, Gaur R.4, Lewin S.1, Freed E.5 1Monash University, Dept. Medicine, Prahran, Australia, 2Peter McCallum Institute, Melbourne, Australia, 3The Burnet Institute, Prahran, Australia, 4Laboratory of Molecular Microbiology, NIAID, NIH, Bethesda, United States, 5HIV Drug Resistance Program, NCI, Virus-Cell Interaction Section, Frederick, United States
MOPEB016 Abstract	Initiation of antiretroviral therapy at higher CD4+ T cell counts reduces incidence of nucleoside analogue toxicities acutely and risk for later development with continued use of these agents in the HIV outpatient (HOPS) cohort Presented by Kathy Wood, United States Lichtenstein K.1, Armon C.2, Moorman A.3, Buchacz K.3, Wood K.2, Brooks J.3, and the HOPS Investigators 1University of Colorado Health Sciences Center, Denver, CO, United States, 2Cerner Corporation, Vienna, VA, United States, 3Centers for Disease Control and Prevention, Atlanta, GA, United States
MOPEA042 Abstract	Investigating the mechanisms of APOBEC-mediated restriction of HIV-1 Presented by Kate N. Bishop, United Kingdom (TBC) Bishop K.N.1, Holmes R.K.1, Verma M.1, Koning F.A.1, Malim M.H.1 1King's College London, Department of Infectious Diseases, London, United Kingdom
MOPEA001 Abstract	Investigating the trafficking and assembly of HIV-1 Presented by Boyan Grigorov, France (TBC) Grigorov B.1, Bosch B.2, Arcanger F.3, Roingeard P.3, Esté J.2, Darlix J.-L.1, Muriaux D.1 1LaboRetro, Unité de virologie humaine INSERM U758, IFR128, ENS, Lyon, France, 2Retrovirology Laboratory IrsiCaixa, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain, 3Inserm ESPRI 3856 – IFR 136, Université François Rabelais, Tours, France
MOPEB063 Abstract	Is CD4 percentage a better marker of immune-suppression than CD4 absolute count in HIV-infected subjects with cirrhosis? Presented by Marco Bongiovanni, Italy (TBC) Bongiovanni M.1, Gori A.1, Cozzi Lepri A.2, Antinori A.3, De Luca A.4, Pagano G.5, Chiodera A.6, Puoti M.7, D'Arminio Monforte A.1 1Clinic of Infectious Diseases, San Paolo Hospital, University of Milan, Milan, Italy, 2Department of Primary care and population sciences, Royal Free and University College Medical School, London, United Kingdom, 3National Institute of Infectious Diseases, L. Spallanzani, IRCCS, Rome, Italy, 4Institute of Infectious Diseases, University Cattolica del Sacro Cuore, Rome, Italy, 5Division of Infectious Diseases, San Martino Hospital, Genova, Italy, 6Division of Infectious Diseases, Macerata Hospital, Italy, Macerata, Italy, 7Clinic of Infectious Diseases, University of Brescia, Brescia, Italy
MOPEA057 Abstract	In vitro mechanistic basis for the rapid selection of K65R in subtype-C HIV-1 Presented by Mark A. Wainberg, Canada Coutsinos D.1, Invernizzi C.F.1, Moisi D.1, Xu H.1, Spira B.1, Brenner B.G.1, Wainberg M.A.1 1McGill AIDS Centre, Montreal, Canada
MOPEA055 Abstract	In vitro selection and characterization of resistance to two new HIV-1 protease inhibitors: CRS-074 and CRS-075 Presented by Alexandre Calazans, Brazil (TBC) Calazans A.1, Lima E.2, Debom R.2, Pacheco O.2, Tanuri A.1, Brindeiro R.1 1Federal University of Rio de Janeiro, Department of Genetics, Rio de Janeiro, Brazil, 2Cristália Farmoquímicos LTDA, São Paulo, Brazil
MOPEC015 Abstract	A molecular survey of the Indonesian HIV epidemic confirms dynamic transmission between vulnerable populations Presented by Claire Ryan, Australia (TBC) Ryan C.1, Merati T.P.2, Turnbull S.1, Wirawan D.3, Bakta I.M.3, Otto B.2, Crowe S.1, Oelrichs R.1 1The Burnet Institute, Pathogenesis and Clinical Research, Melbourne, Australia, 2The Burnet Institute, Denpasar, Indonesia, 3Udayana University, Denpasar, Indonesia
MOPEB089 Abstract	A randomised, placebo-controlled, dose escalation study to determine the safety, tolerability and immunogenicity of an HPV therapeutic vaccine in HIV-positive participants with oncogenic HPV infection of the anus Presented by Jonathan Anderson, Australia Anderson J.1, Hoy J.2, Hillman R.3, Barnden M.4, Eu B.5, McKenzie A.4, Basser R.4 1Carlton Clinic, Carlton, Australia, 2Alfred Hospital, Melbourne, Australia, 3STI Research Centre, University of Sydney, Sydney, Australia, 4CSL Ltd, Melbourne, Australia, 5Prahran Market Clinic, South Yarra, Australia
MOPEB080 Abstract	A wide range of cancers is associated with HIV infection: meta-analysis of studies of cancer in people with HIV/AIDS and in transplant recipients Presented by Andrew Grulich, Australia (TBC) Grulich A.1, van Leeuwen M.1, Falster M.1, Vajdic C.1 1University of New South Wales, National Centre in HIV Epidemiology and Clinical Research, Sydney, Australia
MOPEB006 Abstract	Abacavir hypersensitivity and HLA typing of HIV-infected patients in Taiwan Presented by Chien-Ching Hung, Taiwan, Province of China Sun H.-Y.1, Liu W.-C.1, Wu C.-H.1, Hung C.-C.1, Chang S.-Y.2 1National Taiwan University Hospital, Internal Medicine, Taipei, Taiwan, Province of China, 2National Taiwan University College of Medicine, Clinical Laboratory Sciences and Medical Biotechnology, Taipei, Taiwan, Province of China
MOPEB004 Abstract	Abacavir hypersensitivity and HLA-B*5701 carriage in a Caribbean cohort Presented by SYLVIE ABEL, France (TBC) Abel S.1, Bera O.2, Pierre-Francois S.1, Beraud G.1, Paturel L.2, Liautaud B.1, Cesaire R.2, Cabie A.1 1CHU de Fort-de-France, Infectious Diseases, Fort-de-France, France, 2CHU de Fort-de-France, Virology and Immunology, Fort-de-France, France
MOPEB100 Abstract	An increased risk of bacterial pneumonia in patients interrupting antiretroviral treatment: results from the SMART study Presented by Fred Gordin, United States (TBC) Gordin F.1, Roediger M.2, Clezy K.3, Easterbrook P.4, Girard P.5, Lundgren J.6, Miro J.7, Palfreeman A.8, Rodriguez-Barradas M.9, Slater L.10, Wolff M.11, SMART Study Group and INSIGHT 1VA Medical Center and George Washington University, Washington, DC, United States, 2University of Minnesota, Minneapolis, United States, 3University of New South Wales, Sydney, Australia, 4Kings College, London, United Kingdom, 5Hopital St Antoine, Paris, France, 6Hvidovre University Hospital, Copenhagen, Denmark, 7University of Barcelona, Barcelona, Spain, 8Medical Research Council, London, United Kingdom, 9Baylor College of Medicine, Houston, United States, 10University of Oklahoma, Oklahoma City, United States, 11University of Chile School of Medicine, Santiago, Chile
MOPEA054 Abstract	Analysis of cleavage site evolution following virological rebound on a tipranavir-based regimen Presented by Sonia Tremblay, Canada (TBC) Tremblay S.1, Bourgon L.1, Hall D.2, Elston R.1, Bethell R.1 1Boehringer Ingelheim (Canada) Ltd., Research & Dev, Biological Sciences, Laval, Québec, Canada, 2Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, United States
MOPEA023 Abstract	Antibody protein arrays of CD markers on CD4+ and CD8+ T cells demonstrate that CD8+ T cells discriminate better between HIV disease groups Presented by Jingqin Wu, Australia (TBC) Wu J.Q.1, Belov L.2, Evans K.2, Dwyer D.E.3, Saksena N.K.1 1Westmead Millennium Institute, University of Sydney, Medicine, Sydney, Australia, 2Medsaic Pty Ltd, Sydney, Australia, 3Westmead Hospital, Virology, Sydney, Australia
MOPEA082 Abstract	Anti-HBs and HBV DNA presence in anti-HBc-positive/HBsAg-negative subjects coinfected with HIV and HCV Presented by Joanna Kubicka, Poland (TBC) Kubicka J.1, Kamińska A.2, Burkacka–Firlag E.1, Radkowski M.2 1Regional Hospital of Infectious Diseases, Out-patient Clinic for HIV Infected Patients, Warsaw, Poland, 2Medical University, Warsaw, Poland
MOPEA041 Abstract	APOBEC3G-UBA2 fusion as a potential strategy for stable expression of APOBEC3G and inhibition of HIV-1 replication Presented by Lin Li, China (TBC) Li L.1, Li J.-y.1, Zhao R.Y.2 1Beiing Institute of Microbiology and Epidemiology, Beijing, China, 2Department of Pathology, Department of Microbiology-Immunology, Institute of Human Virology, University of Maryland, Baltimore, United States
MOPEC028 Abstract	Assessing the socio-economic factors that drive HIV/AIDS epidemic in four coastal areas of Akwa Ibom State, Nigeria Presented by Nkechi Iboro, Nigeria (TBC) Iboro N.1, Udoh J.I.2, Samuel I.3, Alpha Medical Services 1General Hospital, Social Service Department, Ikot Ekpene, Nigeria, 2General Hospital, Gynae & Obs Department, Ikot Ekpene, Nigeria, 3General Hospital, Gynae & Obs Department, Uyo, Nigeria
MOPEB069 Abstract	Assessment of renal function in patients starting antiretroviral therapy comparing cystatin C with serum creatinine based formula Presented by Stefan Mauss, Germany (TBC) Mauss S.1, Berger F.1, Schmutz G.1 1Center for HIV and Hepatogastroenterology, Duesseldorf, Germany
MOPEA028 Abstract	Association between non-progression and single mutations in trafficking NEF domains in a cohort of LTNP Presented by María Salgado, Spain (TBC) Salgado M.1, Simón A.1, Soriano V.1, Rodés B.1 1Hospital Carlos III, Servicio de Enfermedades Infecciosas, Madrid, Spain
MOPEC004 Abstract	Blood borne viral transmission networks dynamics in two different high-risk populations in San Francisco Presented by Paulo Telles-Dias, Brazil (TBC) Telles-Dias P.1, Hahn J.2, Lum P.3, Ellman A.4, Martin J.4, Deeks S.3, Busch M.5, Currie S.6, Page-Shafer K.7 1State University of Rio de Janeiro, NEPAD, Rio de Janeiro, Brazil, 2University of California San Francisco, EPI-Center, San Francisco - CA, United States, 3University of California San Francisco, Positive Health Program, San Francisco - CA, United States, 4University of California San Francisco, Dept. of Epidemiology and Biostatistics, San Francisco, United States, 5Blood Systems Research Institute, San Francisco, United States, 6SF Veterans Administration Medical Center, San Francisco, United States, 7University of California San Francisco, Center for AIDS Prevention Studies, San Francisco, United States
MOPEB042 Abstract	Blood markers to assess the degree of liver fibrosis in HIV-HCV co-infected patients might have a high diagnostic performance Presented by Laurence Weiss, France (TBC) Batisse D.1, Perré P.2, Fouchart-Hubert I.3, Michalak S.4, Rousselet M.C.4, Gallois Y.5, Veillon P.6, Lunel F.6, Cales P.3, Weiss L.7 1Hospital, Paris, France, 2Hospital, La Roche Sur Yon, France, 3Hospital, Hepatology, Angers, France, 4Hospital, Anatomopathology, Angers, France, 5Hospital, Biology, Angers, France, 6Hospital, Virology, Angers, France, 7Hospital, Immunology, Paris, France
MOPEA092 Abstract	CD4+ T cell subpopulation distribution and IL-4 production in mono- and co-infected HIV and leprosy patients Presented by Esper Kallas, Brazil Carvalho K.1, Maeda S.2, Marti L.3, Haslett P.4, Kallas E.1 1Federal University of Sao Paulo, Infectious Disease, Sao Paulo, Brazil, 2Federal University of Sao Paulo, Dermatology Disease, Sao Paulo, Brazil, 3Albert Einstein Research Institute, Research, Sao Paulo, Brazil, 4University of Miami, Miami, United States
MOPEB105 Abstract	Central nervous system involvement in syphilis and neurosyphilis among HIV patients in the era of HAART, a population profile Presented by Stacey Aitchison, Australia (TBC) Aitchison S.1, Mijch A.1, Watson K.1 1Bayside Health, Alfred Hospital, Infectious Disease Unit, Prahran, Australia
MOPEB074 Abstract	Chagas disease neurological involvement and HIV infection in Argentina (1992-2006) Presented by Ezequiel Cordova, Argentina (TBC) Cordova E.1, Boschi A.1, Ambrosioni Czyrko J.1, Cudos C.1, Corti M.1 1Infectious Diseases “Francisco Javier Muñiz” Hospital, Infectious Diseases, Buenos Aires, Argentina
MOPEC031 Abstract	Challenges in the selection of the optimal regulatory pathway for microbicides: the capacities of African NRA and international approvals Presented by Claudia Brabazon, Canada (TBC) Brabazon C.1, Novogrodsky N.1, Bains A.2, Caplan G.2 1Faculty of Law, University of Toronto, Toronto, Canada, 2Office of U.N. Special Envoy for HIV/AIDS in Africa, Toronto, Canada
MOPEC042 Abstract	Challenges with risk reduction behavior among HIV discordant couples in a Caribbean island Presented by Avion Quava-Jones, Trinidad and Tobago (TBC) Quava-Jones A.1, Bartholomew C.2 1Medical Research Foundation, Counselling, Arouca, Trinidad and Tobago, 2Medical Research Foundation, Medical Director, Port-of-Spain, Trinidad and Tobago
MOPEA071 Abstract	Changes in neuropsychological functioning, immune suppression and viral load of HIV-1 clade C seropositive subjects from South India – a longitudinal study Presented by Kumarpillai Gopukumar, India (TBC) Gopukumar K.1, Rao S.L.1, Satishchandra P.2, Wilkie J.3, Subbakrishna W.-V.4, Desai A.5, Ravi V.5, Rao B.S.6, Satish K.S.6, Mahendrakumar M.3 1National Institute of Mental Health & Neuro Sciences, Mental Health and Social Psychology, Bangalore, India, 2National Institute of Mental Health and Neurosciences, Neurology, Bangalore, India, 3University of Miami School of Medicine, Miami, United States, 4National Institute of Mental Health and Neurosciences, Biosatistics, Bangalore, India, 5National Institute of Mental Health and Neurosciences, Virology, Bangalore, India, 6Seva Free Clinic, Bangalore, India
MOPEB076 Abstract	Changing prevalence and risk factors for HIV-associated sensory neuropathy (HIV-SN) 1993-2006 in Melbourne, Australia Presented by Cherry Catherine, Australia (TBC) Smyth K.1, Affandi J.2, McArthur J.3, Bowtell-Harris C.4, Mijch A.4, Watson K.4, Costello K.4, Woolley I.4, Wesselingh S.5, Catherine C.5 1Australian National University, Medicine, Canberra, Australia, 2Murdoch University, Perth, Australia, 3Johns Hopkins University, Neurology, Baltimore, United States, 4Alfred Hospital, Melbourne, Australia, 5Burnet Institute, Melbourne, Australia
MOPEB065 Abstract	Chronic renal disease prevalence and risk factors in HIV-infected patients Presented by Hernando Knobel, Spain (TBC) Guelar A.1, Sorli L.1, Montero M.1, González A.1, Saballs P.1, López-Colomés J.L.1, Rodriguez E.2, Orfila A.2, Knobel H.1 1Hospital del Mar, Internal Medicine-Infectious Diseases, Barcelona, Spain, 2Hospital del Mar, Nephrology, Barcelona, Spain
MOPEA025 Abstract	Clearance of transfusion-acquired, attenuated nef-deleted HIV-1 infection by a long-term non-progressor with heterozygous CCR5 delta32 and HLA-B57 genotype Presented by John Zaunders, Australia (TBC) Zaunders J.1, Dyer W.B.2, Churchill M.3, Munier M.L.4, Cunningham P.1, Suzuki K.1, Wang B.5, Wilkinson J.6, Riminton S.7, Curmi P.8, Gelgor L.4, Kaldor J.4, Saksena N.5, Cooper D.A.4, Sullivan J.S.2, Gorry P.R.3, Learmont J.C.2, Kelleher A.D.4 1St. Vincent's Hospital, Centre for Immunology, Sydney, Australia, 2Australian Red Cross Blood Service, Sydney, Australia, 3Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Australia, 4National Centre in HIV Epidemiology and Clinical Research, UNSW, Sydney, Australia, 5Westmead Millenium Institute, Sydney, Australia, 6Biotron Limited, Sydney, Australia, 7Concord Repatriation General Hospital, Sydney, Australia, 8School of Physics, UNSW, Sydney, Australia
MOPEA077 Abstract	Clinical and epidemiological features of HIV Dual infections in Argentina Presented by Juan Ambrosioni Czyrko, Argentina (TBC) Ambrosioni Czyrko J.1, Andreani G.2, Pugliese D.1, Redini L.1, Oliva S.M.1, Carr J.K.3, Martínez Peralta L.2, Benetucci J.1 1Infectious Diseases 'Francisco Javier Muñiz' Hospital, Infectious Diseases, Buenos Aires, Argentina, 2National Reference Center for AIDS., Microbiology Department, University of Buenos Aires., Buenos Aires, Argentina, 3Institute of Human Virology, University of Maryland Biotechnology Institute, Epidemiology Dept, Baltimore, MD, United States
MOPEB027 Abstract	Clinical and microbiological features of HIV associated tuberculous meningitis in Viet Nam Presented by Mili Estee Torok, Viet Nam (TBC) Torok M.E.1, Chau T.T.H.2, Mai P.P.2, Phong N.D.2, Dung N.T.2, Chuong L.V.2, Hien T.T.2, Farrar J.J.1 1Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam, 2Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam
MOPEC033 Abstract	Clinical practice during a pre screening trial for a phase I HIV vaccine in Lusaka, Zambia Presented by William Kilembe, Zambia Kancheya N.1, Vwalika C.1, Kilembe W.2, Henderson F.1, Fast P.3, Allen S.4, Zambia Emory HIV Research Project 1Zambia Emory HIV Research Group, Lusaka, Zambia, 2Zambia Emory HIV Research Group, Clinical, Lusaka, Zambia, 3IAVI, Clinical, Boston, United States, 4Zambia Emory HIV Research Group, Atlanta, United States
MOPEC044 Abstract	Co-infection of HIV, HCV, HBV and the associated risk behaviors among injection drug users in two northeastern states of India Presented by Biswajyoti Borkakoty, India Borkakoty B.1, Mahanta J.2, Das H.K.3, Chelleng P.k.3 1Regional Medical Research Centre for NE region (Indian Council of Medical Research), Virology, Dibrugarh, India, 2Regional Medical Research Centre for NE region (Indian Council of Medical Research), Microbiology, Dibrugarh, India, 3Regional Medical Research Centre for NE region (Indian Council of Medical Research), Clinical Research, Dibrugarh, India
MOPEB104 Abstract	Co-infection with Treponema pallidum and HIV: effect of the CD4 cell count and penicillin dosage in the response of syphilis to therapy Presented by Roberto Andrade, United States (TBC) Andrade R.1, Villareal-Williams E.1, Risser J.2, Thornton L.3, Kubala A.3, Zerai T.4, Musher D.1 1Baylor College of Medicine, Houston, Texas, United States, 2University of Texas School of Public Health, Division of Epidemiology and Disease Control, Houston, Texas, United States, 3Houston Department of Health and Human Services, STD Surveillance, Houston, Texas, United States, 4Thomas Street Health Center, Houston, Texas, United States
MOPEA074 Abstract	Co-infection with Trypanosoma cruzi (Chagas´ disease agent) decreases HIV-1 transcription in human placenta Presented by Guillermina Laura Dolcini, Argentina (TBC) Dolcini G.1, Solana M.E.2, Andreani G.1, Celentano A.M.2, Martínez Peralta L.1 1National Reference Center for AIDS, Microbiology Department, School of Medicine, University of Buenos Aires, Buenos Aires, Argentina, 2Laboratory of Parasitology, Microbiology Department, School of Medicine, University of Buenos Aires, Buenos Aires, Argentina
MOPEC035 Abstract	Communities advocate for themselves: good information is crucial for clinical trials participation in pre-exposure prophylaxis (PREP) studies Presented by Pedro Goicochea, Peru (TBC) Goicochea P.1, Lama J.R.1, McConnell J.2, Leon R.1, Page-Shafer K.3, Levy V.4, Sanchez J.1, Grant R.2 1Asociacion Civil Impacta Salud y Educacion, Lima, Peru, 2Gladstone Institute of Virology and Immunology, San Francisco, United States, 3University of California San Francisco, San Francisco, United States, 4Stanford University, Standford, United States
MOPEB038 Abstract	Comparison between HIV/HCV co-infection and HCV mono-infection in a cohort of heroin users in Liuzhou, China Presented by Yi Tan, Hong Kong (TBC) Tan Y.1, Lee S.S.1, Chen L.J.2, Wei Q.H.2, Lai W.S.2, Wei L.2, Meng J.H.2, Sung J.1, He M.L.1 1The Chinese University of Hong Kong, Stanley Ho Centre for Emerging Infectious Diseases, Hong Kong, Hong Kong, 2Liuzhou Centre for Disease Control and Prevention, Liuzhou, Guangxi, China
MOPEB024 Abstract	Comparison of tuberculin skin test and T cell based diagnostic test for identification of latent TB among HIV infected patients in Georgia (2006) Presented by Tengiz Tsertsvadze, Georgia (TBC) Tsertsvadze T.1, Gabunia P.1, Baloyan D.1 1Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia
MOPEA065 Abstract	Complete knockdown of CCR5 and CXCR4 by siRNAs confers strong protection against HIV-1 infection in CD34 cell derived macrophages in vitro and SCID-hu derived thymocytes in vivo Presented by Joseph Anderson, United States (TBC) Anderson J.1, Akkina R.1 1Colorado State University, Microbiology/Immunology/Pathology, Fort Collins, United States
MOPEA059 Abstract	Conservation patterns of HIV-1 RT connection and RNase H domains: identification of new antiretroviral resistance mutations Presented by André Felipe Andrade Santos, Brazil (TBC) Santos A.F.A.1, Lengruber R.B.1, Soares E.A.J.M.1, Sousa T.M.1, Schrago C.E.G.1, Jere A.2, Sprinz E.3, Martinez A.M.B.4, Silveira J.4, Sion F.5, Pathak V.K.2, Soares M.A.1 1Universidade Federal do Rio de Janeiro, Departamento de Genética, Rio de Janeiro, Brazil, 2National Cancer Institute-Frederick, Frederick, United States, 3Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil, 4Fundação Universidade do Rio Grande, Rio Grande, Brazil, 5Hospital Universtário Gaffrée e Guinle, Rio de Janeiro, Brazil
MOPEB021 Abstract	Correlation of clinical data with reactivity in the interferon- release assay for tuberculosis antigens in HIV-infected patients Presented by Maximilian C. Aichelburg, Austria (TBC) Aichelburg M.C.1, Makristathis A.2, Breitenecker F.1, Eltz S.1, Aichelburg A.C.3, Rieger A.1, Kohrgruber N.1 1Vienna Medical School, Department of Dermatology, Division of Immunology, Allergy and Infectious Diseases, Vienna, Austria, 2Vienna Medical School, Department of Clinical Microbiology, Institute of Hygiene and Medical Microbiology, Vienna, Austria, 3Pulmological Centre SMZ Baumgartner Höhe, Otto Wagner-Hospital, II. Medical Department, Vienna, Austria
MOPEA075 Abstract	Couple counseling training for health care workers of PMTCT program in Thailand Presented by Nipunporn Voramongkol, Thailand (TBC) Voramongkol N.1, Koetsawang S.2, Pattarakulwanich S.1, Leartvanangkul C.1 1Department of Health, Ministry of Public Health, Bangkok, Thailand, 2Reproductive Health for Quality of Life Development Association of Thailand, Bangkok, Thailand
MOPEA073 Abstract	Database on HIV/AIDS/STI Indian research studies Presented by Ssandeep Bhalla, India (TBC) Bhalla S.1 1Resource Centre For Sexual Health and HIV/AIDS, DFID, Delhi, India
MOPEC034 Abstract	Declining trends in the incidence of HIV seropositivity in blood donations by implementing the national blood safety policy 2002- a South Indian city experience Presented by doraisamy rajesh, India (TBC) Rajesh D.1, Manivasan K.1, Radakrishnan K.2 1Chennai AIDS Prevention and Control Society, Chennai Corporation, Chennai, India, 2Department of Transfusion Medicine, Dr. M.G.R. Medical University, Chennai, India
MOPEA009 Abstract	Defect responsiveness to TLR9 stimuli in progressive HIV-1 as well as HIV-2 infections disclosed by whole blood stimulation Presented by Salma Nowroozalizadeh, Sweden (TBC) Nowroozalizadeh S.1, Månsson F.2, Repits J.3, da Silva Z.4, Pereira C.4, Biague A.4, Albert J.1, Holmgren B.3, Aaby P.5, Norrgren H.2, Fenyö E.M.3, Jansson M.1 1Swedish Institute for Infectious Disease Control, Dept Virology, immunology and vaccinology, Stockholm, Sweden, 2Lund University, Dept Infectious Diseases, Lund, Sweden, 3Lund University, Dept Laboratory Medicine, Lund, Sweden, 4The National Laboratory for Public Health, Bissau, Guinea-Bissau, 5Bandim Health Center, Bissau, Guinea-Bissau
MOPEB079 Abstract	Depressive symptomatology and suicidal ideation among HIV-infected women in India Presented by Salma Pothiawala, United States (TBC) Pothiawala S.1, Menezes L.1, Kim H.2, Joshi A.3, Deshpande A.3, Sinnott J.1 1University of South Florida College of Medicine, Department of Infectious Disease and International Medicine, Tampa, United States, 2University of South Florida, Center for Collaborative Research, Tampa, United States, 3Government of Maharashtra, Sir JJ Government Hospital, Mumbai, India
MOPEA044 Abstract	Determination of the frequency of HIV-1 superinfection in Cameroon using the Heteroduplex Mobility Assay (HMA) Presented by Phillipe Nyambi, United States (TBC) Powell R.1, Urbanski M.2, Burda S.2, Nyambi P.3 1New York University School of Medicine, Microbiology, New York, United States, 2New York University School of Medicine, Pathology, New York, United States, 3New York University School of Medicine and VA Medical Center, New York, New York, United States
MOPEA080 Abstract	Development of an in vitro model to assess the interaction of HIV and hepatitis B virus (HBV) in human hepatocytes Presented by David Iser, Australia (TBC) Iser D.1, Solomon A.2, Wightman F.2, Saleh S.2, Cameron P.2, Warner N.3, Desmond P.1, Locarnini S.3, Lewin S.2 1St. Vincent's Hospital, Department of Medicine, The University of Melbourne, Fitzroy, Australia, 2Monash University, Department of Medicine, Melbourne, Australia, 3Victorian Infectious Diseases Reference Laboratory, North Melbourne, Australia
MOPEA062 Abstract	Differential kinetics of drug resistance acquisition in HIV-1 of subtypes B and C Presented by Esmeralda Augusta Jardim Machado Soares, Brazil (TBC) Soares E.A.J.M.1, Santos A.F.A.1, Sousa T.M.1, Sprinz E.2, Martinez A.M.B.3, Silveira J.3, Tanuri A.1, Soares M.A.1 1Universidade Federal do Rio de Janeiro, Departamento de Genética, Rio de Janeiro, Brazil, 2Universidade Federal do Rio Grande do Sul, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil, 3Fundação Universidade do Rio Grande, Departamento de Patologia, Rio Grande, Brazil
MOPEA015 Abstract	Differential M1 and M2 activation of monocyte-derived macrophages inhibits R5 HIV-1 replication Presented by Guido Poli, Italy (TBC) Cassol E.1, Alfano M.1, Poli G.1 1San Raffaele Scientific Institute, Immunology and Infectious Diseases, Milano, Italy
MOPEA019 Abstract	Differential modulation of the ISG15 specific Herc5 ubiquitin ligase upon infection by Nef-open versus Nef-deleted viruses Presented by Dominique Mahé, France (TBC) Mahé D.1, Rahm N.1, Gloeckler L.1, Beyer C.1, Brignon N.1, Doridot S.1, Werner S.1, Gut J.-P.1, Aubertin A.-M.1 1INSERM U778, Université louis Pasteur, Strasbourg, France
MOPEA035 Abstract	Differentiation stage, activation and apoptosis of T cells in a cohort of long-term non-progressors with divergent CD4 outcome Presented by Mariola López, Spain (TBC) López M.1, Soriano V.1, Rodés B.1, Cascajero A.1, González-Lahoz J.1, Benito J.M.1 1Hospital Carlos III, Molecular Biology Laboratory, Madrid, Spain
MOPEA088 Abstract	Discrimination of clinical GBV-C isolates in accordance with their HIV inhibitory phenotype - impact of the GBV-C envelope glycoprotein 2 on HIV entry impairment Presented by Susan Jung, Germany (TBC) Jung S.1, Tenckhoff S.2, Helm M.3, Mueller R.1, Hess G.4, Fleckenstein B.1, Reil H.1 1University Hospital Erlangen, Department of Clinical and Molecular Virology, Erlangen, Germany, 2University Hospital Leipzig, Leipzig, Germany, 3Practice Abelein & Helm, Nuremberg, Germany, 4Roche Diagnostics, Mannheim, Germany
MOPEC029 Abstract	Distribution of clean delivery kits strengthens HIV prevention efforts Presented by James Ssenfuka, Uganda (TBC) Ssenfuka J.1, Nassamula H.2, Kintu P.2, Nsabagasani X.2 1Ministry of Health, OBSGYN, Kampala, Uganda, 2UPHOLD, M&E, Kampala, Uganda
MOPEA047 Abstract	Effect of HIV-1C infection on the NF-kB signaling pathway: a comparison with viral load Presented by Keikantse Matlhagela, Botswana (TBC) Matlhagela K.1, McLane M.F.2, Wu J.3, Novitsky V.4, Essex M.4 1Botswana-Harvard School of Public Health AIDS Initiative Partnership for HIV Research and Education, Gaborone, Botswana, 2Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, United States, 3Harvard School of Public Health, Biostatistics & Computational Biology, Boston, United States, 4Botswana-Harvard School of Public Health AIDS Initiative Partnership for HIV Research and Education, Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, United States
MOPEA061 Abstract	Effect of naturally occurring mutations in the recombinant strains of HIV-1 env gp41 N-helix region (aa 25-45) on T-20 binding and viral tropism Presented by Nitin Saksena, Australia (TBC) Saksena N.1, Shah M.2, Wang B.2, Ng K.P.3, Dwyer D.4, Kamarulzaman A.3, Lau K.2, Faudon J.F.5 1Westmead Millennium Institute, Retroviral Gentics, Kellyville, Australia, 2Westmead Millennium Institute, Retroviral Gentics, Sydney, Australia, 3University of Malaya, Microbiology and Immunology, Kuala Lumpur, Malaysia, 4Westmead Millennium Institute, ICPMR, Sydney, Australia, 5Viralliance, Paris, France
MOPEB060 Abstract	Efficacy and safety of atazanavir in HIV-infected patients with liver cirrhosis Presented by JOSE MANUEL HERMIDA DONATE, Spain (TBC) Hermida Donate J.M.1, Quereda C.1, Moreno A.1, Hernandez B.1, Rodriguez M.A.2, Dronda F.1, Perez-Elias M.J.1, Casado J.L.1, Moreno S.1 1Hospital Ramón y Cajal, Infectious Diseases, Madrid, Spain, 2Hospital Ramón y Cajal, Pharmacy, Madrid, Spain